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Introduction
Unlike other reports on drug misuse, this report measures service contact across the entire
spectrum of drugs services in Merseyside and Cheshire. It provides information on outcomes of
drug treatment and analyses trends in drug use relevant to the key performance indicators of the
Government’s 10 year drug strategy.  This is the fourth in an annual report series presenting data
collected from the four different types of drug services (specialist drug services (SDS), agency
based syringe exchange schemes (SES), pharmacy based syringe exchange schemes (Pharmacy)
and outreach services (Outreach) in Merseyside and Cheshire.  With four years of reporting it is
possible to begin more robust analyses of trends, in particular looking at changes in the preva-
lence of certain drugs used, age ranges and proportions of females and young people who are
reported.  This enables us to assess achievement of targets set in the Government’s 10 year
drug strategy, Tackling Drugs to Build a Better Britain 
1 and the First Annual Report and National
Plan 
2 of the UK Anti-Drugs Co-ordinator.  For example this report examines the proportions of
under 25 year olds reporting drug use, repeat offending, referral from the criminal justice system,
number in treatment, particularly the young and those using heroin and cocaine.    
This year a new table has been incorporated in Section One (contacts with SDS) which analyses
the numbers and proportions of individuals discharged drug free in previous years and who then
reappear at treatment services over a period of the next two years.  Three new figures have
been included in Section Two (SES), giving four year trends in new users reporting use of heroin,
methadone and anabolic steroids as their main drug.
Specialist Drug Services
During 1999, 7,772 individuals were reported as being in contact with the 28 specialist drug ser-
vices in Merseyside and Cheshire (see Table 1.1)  A map and list of all reporting agencies can be
found in Appendices II and III.  The number of reports these agencies made to the Drug Misuse
Database (DMD, the National data set) was considerably lower - only 2,629 individuals - display-
ing the level to which the DMD under represents prevalence of drug user contacts with treat-
ment agencies and agency activity (the DMD records only new episodes of presenting drug use).
Generally, those agencies with the greatest differential between clients in contact and those
reported to the DMD are those with long term treatment aims.  For example, Wirral Drug Service 
reported only around one sixteenth of clients seen during the year to the Drug Misuse Database.
Executive SummaryHowever Wirral Drug Service provide long term maintenance prescribing services and such
services will naturally exhibit a low turn over of clients.  Conversely, those services whose 
aim is shorter term contact, typically detoxification, exhibit a high turn over with all or nearly
all of their clients representing new agency episodes and therefore being reported to the 
DMD.  For example the Kevin White Unit, a residential service,reported 95.3% of clients to 
the DMD.  These examples exhibit how difficult it is to estimatethe extent of service use from 
the current national database and therefore the need for local information on the actual number
of individuals accessing services and the outcomes of their treatment.  Such intelligence is provided 
in Section One.
The majority of SDS clients reported to the Merseyside and Cheshire prevalence database
were male (the female to male ratio was 1:2).  The proportion of females reported has
risen between 1996 and 1999 from 28.6% in 1996 to 31.3% in 1999.  See Table 1.2.  This
rise in reports of females is encouraging in the light of the Government's drug strategy which
requires that women should have access to appropriate support services.  The most common
age group for both males and females was 30 to 34 followed by 25 to 29.  Thus, SDS clients 
are the oldest group reported to the Drug Monitoring Unit as both SES and Pharmacies reported 
25 to 29 as the most common age group.  Age of individuals reported by outreach services 
is not recorded.  Female SDS clients were slightly younger than their male counterparts, 
with 18.8% aged under 25 (the age range targeted in Government strategy) compared 
to 12.3% of males.  This represents a fall in the numbers of young people reported (14.4%,  
overall, in 1999 compared to 17.0% or over in each of the previous two years) and, although 
this would appear to be in line with the Government's objective of reducing the number 
of young people reporting drug use (KPI I, see Box 1 and KPT 1, see Box 2), it could be 
indicative of young people not being attracted into services, rather than their reduced drug 
use.  The majority of clients of SDS were resident in the Health Authority in which they 
sought treatment.  However, only 16 individuals were reported as having no fixed abode (NFA) 
in 1999.  This may be because those who have no permanent or temporary address may not 
wish to have this recorded or do not perceive drugs services as being appropriate to their 
needs or be willing to enter them for treatment.
The proportion of clients who were still active (i.e. still in contact with a treatment agency) at
the end of the reporting period has risen since 1996 from 59.0% to 75.3% in 1999, (see
Table 1.6).  That is, more than three quarters of all clients seen by services during 1999 were
still receiving treatment from those services at the years end.   As in 1998, nearly two thirds of
users (61.3%) or 81.3% of all ‘active’ users, were in receipt of methadone (see Table 1.7), a rise
from 58.6% in 1997.  Amongst non-active clients (those no longer in contact with services),
more were reported as having left services drug free than any other category although the rate
has fallen from 19.3% in 1997 to 9.4% in 1999.   However, drug free status does not pre-
clude relapse at a later date and of the 1,284 individuals who were discharged drug free in
1997 nearly a third re-contacted services in 1998 and an additional third re-contacted services
during 1999.  In other words, of the 1,284 individuals discharged drug free in 1997, 40.0% had
re-entered services by the end of 1999.  This pattern repeats in 1998 with a third of those dis-
charged drug free contacting services in 1999, (see Table 1.8).
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As in previous years, sixteen agency based syringe exchange schemes reported data to the
Drug Monitoring Unit.  The small, steady decline in numbers of users seen by these SES agen-
cies reported in previous years has been arrested, with a similar number of individuals (3,690)
reported in 1999 as in 1998.  This, however,  is still lower than in 1996, when 3,852 individu-
als were reported.  For new users, 1999 saw an increase to 1,500 (40.7% of all users) com-
pared to 1,322 (37.0%) in 1998.  Only in 1996 were more new users reported (1,983 or
51.5% of all users), see Table 2.1.  The number of visits made by these individuals (18,859)
was similar to 1998.  The average number of visits made by each client was 5.1, compared to
5.2, 4.6 and 4.9, respectively, in each of the preceding years.  
As in previous years, the proportion of males attending SES was 85.7% (all users) and 87.0%
(new users) giving female to male ratios of 1:6.0 and 1:6.7, respectively, see Table 2.3.  These
proportions remained largely unchanged over the last three reporting years.  Despite the
Government strategy’s emphasis on increasing the availability of drug services for women, SES
continue to represent the lowest proportion of females reported by any agency type.  South
Cheshire saw the greatest proportion of females (17.5% of all users and 18.7% of new users
were female) whilst North Cheshire and St Helens and Knowsley reported less than 10% of all
and new users as female.  High or rising numbers of anabolic steroid (AS) users, who are pre-
dominantly male, in these Health Authorities may account for this low proportion of female
attendance at SES.  The most commonly reported drug amongst users and new users was
heroin (49.1% and 44.6%, respectively) as in previous years.  However the proportions of
reported heroin use had generally fallen over the last four years and new users reporting heroin
were slightly lower than in the previous two years (see Table 2.6a and Figure 2.4c).  In South
Cheshire heroin and methadone use together accounted for around 70% of all reported drug
use, however heroin use rose from 38.9% of new users in 1996 to 65.8% in 1999 while
reported methadone use fell from 27.2% of new users in 1996 to 7.1% in 1999.  This may
signify a move away from the use of prescribed drugs to street drugs.  Reports of AS use are
still rising, from 25.1% of users in 1998 to 28.3% in 1999 and from 33.6% of new users to
37.4% with particularly high rates in North Cheshire (56.7% of new users) and rising rates in
Sefton and St Helens and Knowsley.  Reports of methadone use continued to fall (from12.8%
of all users and 10.6% of new users in 1996 to 8.6% of all users and just 2.9% of new users in
1999).
Overall the most common age group was 25 to 29 (see Table 2.4), although female users were
equally likely to be aged 30 to 34.  Despite a trend of reducing numbers of under 25 year olds
(a group targeted by the Government’s drug strategy) attending SES between 1996 and 1998,
the overall proportions of all and new young (under 25) users has risen slightly in 1999 to
21.0% and 30.6% respectively.  However, they remain considerably below 1996 rates (29.7%
and 40.2%).  Most drug use was concentrated in the 25 to 34 age range, accounting for over
half (57.5%) of all users and 61.0% of heroin users, (see Table 2.8).  Only a fifth (19.5%) of
heroin users were under 25.  AS users represented a slightly younger age group with 60.8%
being in the 20 to 29 age range and only 13.7% aged over 35, compared to 37.6% of
methadone users and 19.5% of heroin users.  Users of methadone were generally older, with
54.5% concentrated in the 25 to 34 age bracket but 29.1% in the 35 to 39 age bracket and
8.5% being aged 44 or over.
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the steady rise since 1997 (14.7% of users).  Also a higher proportion (51.1%) were new to
services in 1999 than in either of the previous two years (50.5% and 48.7%, respectively, see
Table 2.9).  This suggests a polarisation of client contact with increasing numbers engaging in
only a brief period of contact (one year or less) while those who break through the one year
barrier are likely to remain in contact for many years.  The proportion of new users who were
in receipt of treatment  for drug misuse continued to fall, from 30.0% in 1996 to 15.0% in
1999, (see Table 2.12).  In part this could be the result of rising numbers of AS users in contact
with SES, who may see their drug taking as recreational rather than problematic.
Pharmacy Based Syringe Exchange Schemes
In 1999, a total of 59 Pharmacies reported attributable data, with those in Liverpool Health
Authority providing attributable reporting for the first time in 1999.  Pharmacies in Sefton and St
Helens and Knowsley Health Authorities had begun attributable reporting in 1998.  Overall
5,259 individuals were reported.  When double counting across Health Authorities was exclud-
ed the total number of recorded users was 5,536 and the number of new users was 3,880.
This represents a considerable fall in numbers of users since 1998.  This may be accounted for
by the changes in reported activity within Liverpool Health Authority where the number of
users fell from 11,421 in 1998 to 1,581 in 1999.  As these figures are based on attributable
data they therefore represent a more accurate measure of the prevalence of drug users in 
contact with Pharmacies.  Year on year reporting from all other Health Authorities is compara-
ble with previous years.  A total of 3,466 users and 2,231 new users being reported in 1998
and 3,995 users and 2,342 new users were reported in 1999. Changed levels of reporting
from Liverpool based pharmacies may be the result of the start of the new reporting method,
with mostly only new individuals being reported.  Furthermore, fewer Pharmacies in Liverpool
reported in 1999 (12) than in 1998 (17).
The proportion of females reported by Pharmacies rose slightly over the last four years from
17.2% of all users and 6.9% of new users in 1996 to 20.2% of all users and 20.5% of new
users in 1999.  The female to male ratio in 1999 was 1:3.9 for all users and new users.  The
most common age group for both male and female users and new users was 25 to 29, repre-
senting an ageing population of female Pharmacy clients - in 1998 female users and new users
were more likely to be aged between 20 and 24.   However, females presenting at Pharmacy
syringe exchanges were generally younger than males, with 31.5% of all female users and
29.1% of new female users being aged under 25, compared to 22.1% and 20.8% of males. 
Outreach Services
During 1999, 3,316 individuals were reported by Merseyside and Cheshire Outreach services,
of whom 1,470 were new to services, (see Table 4.1).  This represents 19% fewer users and
12% fewer new users than in 1998.  However only nine agencies contributed Outreach data
compared to twelve in previous years.  More contacts were reported in 1999 (15,323) than in
1998 (14,983).  St Helens and Knowsley Outreach services reported the highest proportion of
new users with over two thirds of all users (79.2%) being new to services in 1999.  Outreach
services saw by far the highest proportion of females of all services reporting to the Drug
Monitoring Unit.  For the first time outreach reported more females than males.  Around two
10thirds of all users (65.6%) and new users (65.0%) were female, (see Table 4.3).  In Liverpool,
where some Outreach services (eg those provided by the Maryland Centre) are specifically
aimed at females, in particular female prostitutes, nearly all new clients (98.6%) were female.
Wirral has similarly targeted services and reported 96.8% of their new clients as female.  Sefton
and St Helens and Knowsley reported the lowest proportion of new female clients (38.3% and
40.1%, respectively).  However this is still a higher proportion than SDA and SES.  These fig-
ures are encouraging in terms of the Government’s drug strategy which emphasises the inclu-
sion of females in treatment and supportive services.  Outreach services may represent a ‘gate-
way’ into more formal services and this rise in females seen by outreach workers may lead to
increased numbers in treatment.
The most commonly recorded single drug of use was heroin, accounting for 53.6% of all users
and 43.3% of new users.  In 1998, 54.6% of all users and 50.5% of new users reported hero-
in as their main drug of use.  Data for new users are not available for previous years.
However, poly drug use (‘various drugs’) reports, which had risen from 25.4% of new users in
1998 to 29.6% in 1999, could include heroin use, or use of any of the other individually
recorded drugs.  Poly drug use was more common amongst new users in Wirral (37.3% of
new users) than was heroin (32.9% of new users).  Anabolic steroids were rarely reported as
the main drug of use, accounting for just 1.3% of all and new users.  This contrasts with reports
from agency based syringe exchanges which have been reporting increasing numbers of AS
users, particularly in North Cheshire, Sefton and St Helens and Knowsley.  Of those new 
outreach users who reported primary methadone use, 84.1% also stated that they were in
receipt of a prescription as treatment for drug dependency.  The most commonly reported
client type for all users and new users was non-injecting drug user (36.6% and 38.2%, respec-
tively) (see Table 4.5).  Clients were most likely to have been introduced to the outreach work-
er by another client (37.3% of all users and 30.8% of new users).  
Outreach clients were asked if they were attending an SES at the time of first contact and
10.9% of new users stated that they were, compared to 9.5% in 1998.  A pilot project to col-
lect attributable data from outreach clients began at the Maryland Centre in 2000 and in future
years it will be possible to assess more accurately the numbers of outreach clients who are also
in contact with other specialist drug services.  The most common setting for the contact
between outreach worker and client was in the clients’ home (51.2%) followed by contacts in
the street (31.6%).  In Liverpool, however, 98.8% of contacts were street based, reflecting  in
part higher levels of work with prostitutes.
Multi-Agency-Type Visitors
Altogether 14,760 individuals were reported to SDS, SES and Pharmacy (Outreach data does
not include attributor data so cannot be included in this analysis).  Of the 9,310 individuals
reported by SDS in 1999 and for whom full attributor data had been provided, a fifth (1,816
individuals or 19.5%) also visited one or both types of syringe exchange.  Of this group access-
ing SDS and SES, 4.6% (425 individuals) visited both types, 8.7% (813 individuals) visited a
pharmacy and SDS and 6.2% (578 individuals) visited SES and SDS services, (see Figure 5.1).
This represents considerable numbers of individuals who are receiving treatment at SDS for
their drug problems, but who are continuing to inject.  Of those 7,266 individuals who visited a
syringe exchange (pharmacy or agency based), only 706 individuals, (or 8.9%) visited both
types suggesting that the two different types of syringe exchanges are attracting different popula-
tions of injecting drug users.
11Monitoring Drug Misuse in Merseyside and Cheshire
In Merseyside and Cheshire, as well as collecting data from drug treatment services for inclusion
in the Drug Misuse Database (DMD), four additional data sets are collected: period prevalence
data which is an annual census of all individuals in contact with specialist drug services (SDS);
agency based syringe exchange schemes (SES); pharmacy based syringe exchange schemes
(Pharmacy) and outreach service (Outreach) data.  These data sets may be used to provide a
profile of all drug users in contact with local services and have been collected over the last three
years with some data also being collected in 1996.  This now enables us to analyse three, and
in some cases, four year trends.  Such trends are essential to estimate progress towards the tar-
gets laid out in the Government’s 10 year drug strategy Tackling Drugs to Build a Better Britain 
1
(see Box 1) and those in the First Annual Report and National Plan 
2 (see Box 2).  Whilst the
DMD remains the only national source of data on drug misusers, the current definition of those
who should be reported (new agency episodes ie those who present for the first time and
those who present after a break in contact of six months or more) means that they severely
under-report prevalence of drug misuser contact with services and levels of agency activity.
Consequentially, DMD data cannot be used to measure service use, outcomes of treatment or
provide any useful estimate of the broader levels of drug misuse outside of specialist drugs agen-
cies.  The aim of this report is to provide the necessary epidemiology to inform service devel-
opment, support drug misuse policy and strategy and provide the fundamental information
against which progress towards public health targets can be measured.
Policy developments in 1999: Drug treatment and the criminal justice system
The Government’s drug strategy places particular emphasis on getting more drug users (who
would benefit) into treatment and in particular to divert those individuals who come into contact
with the criminal justice system (CJS)  away from criminality and into a treatment setting.  There
is a well established link between drug use and crime
3 with the cost of supporting a drugs habit
potentially running into hundreds of pounds each week.  As the majority of drug users are not in
employment
4 the most likely source of funding will come from acquisitive crime
5,6. Although
incarceration should curtail prisoner access to drugs, long term imprisonment has not been
observed to stop individuals taking drugs
7 and even in prison sometimes drugs may be widely
available
7.  Those who abstain during incarceration and recommence drug taking upon release
risk the added danger of overdose due to reduced tolerance after abstinence.  Prison may also
have a role in initiating drug use in those who have previously abstained
8.  Furthermore, many
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prisoners, particularly females, who declare drug problems whilst in prison have not been in
attendance at drug services prior to incarceration
9 suggesting that they have not perceived their
drug taking as problematic.  Consequentially, on release they are likely to continue drug taking
and engage in associated criminal activity.
Tackling Drugs to Build a Better Britain: 
Key Objectives (KO) and Objectives 
KPI 1 Reduce the proportion of people under 25 reporting use of illegal drugs in the
last month and previous year.
1.1 Increase levels of knowledge of 5 - 16 year olds about risks and 
consequences of drug misuse
1.2 Delay age of first use of illegal drugs
1.3 Reduce exclusions from schools arising from drug-related incidents
1.4 Reduce number of people under 25 using heroin
1.5 Increase access to information and services for vulnerable groups
KPI 2 Reduce levels of repeat offending amongst drug misusing offenders.
2.1 Increase the number of offenders referred to and entering treatment 
programmes as a result of arrest referral schemes, the court process and               
post-sentencing provision
2.2 Reduce levels of crime committed to pay for drug misuse
2.3 Reduce drugs market places of particular concern to local communities
2.4 Reduce levels of drug-related absenteeism/dismissals from work
2.5 Reduce numbers of road deaths/injuries where drugs are a contributory factor
KPI 3 Increase participation of problem drug misusers, including prisoners, in drug    
treatment programmes which have a positive impact on health and crime.
3.1 Increase the proportion of drug misusers in contact with drug services
3.2 Reduce the proportion of drug misusers who inject and the proportion    
of those sharing injecting equipment over the previous three months.
3.3 Reduce numbers of drug related deaths
3.4 Reduce the number of drug misusers being denied immediate access to        
appropriate treatment
KPI 4 Reduce access to drugs amongst 5-16 year olds
4.1 Increase the effectiveness of the overseas diplomatic and operational effort
4.2 Increase the value of illegal drugs seized in or prevented from entering  the UK
4.3 Increase the number of trafficking groups disrupted or dismantled
4.4 Increase the number of offenders dealt with for supply offences
4.5 Increase the proportion of trafficker assets identified, and the proportion 
confiscated/recovered
4.6 Reduce prisoner access to drugs
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Research has shown that treatment may have a positive effect on both drug taking behaviour
and criminal activity
10,11,12. Three main approaches to the diversion of drug using offenders into
treatment services have been developed.  These are Drug Treatment and Testing Orders
(DTTO), arrest referral schemes (ARS) and Young Offender Teams (YOTs).  All three schemes
aim to make contact with drug users at a point of crisis, ie at arrest or pre-sentence report
stage of probation, when motivation to make lifestyle changes may well be high.  Funding has
also been made available for the provision of drug treatment services within prisons in order to
maximise the opportunity of a controlled environment in which to help prisoners with drug
problems to become drug free.  These are mostly run by local community teams.
Arrest Referral Schemes (ARS) have been available for many years and allow access to
arrestees at the earliest stage, usually in the police station cell.  In old models of ARS police offi-
cers in the station gave out printed information on local services to those individuals arrested
for drugs related offences.  However, this meant that drug taking individuals arrested for other
crimes, such as burglary, which could be related to their drug use, were not included.  Further
problems included arrestee mistrust of the police and low take up of referral
13.  More recent
schemes have been developed along proactive lines where a member of a local drug team is
located in a police station with easy access to all arrestees who wish to take advice about a
drugs problem, regardless of the offence for which they were arrested.  Initial assessment is
undertaken in the police custody suite and a referral on to appropriate services is made.  Speed
of referral is of great importance to the take up of referral.  The longer the delay between ARS
contact and the appointment at a drug service, the less likely arrestees are to attend.  Many
schemes are voluntary but ‘caution plus’ schemes and bail support contain an element of coer-
cion.  Both require the arrestee to admit the offence(s) freely and must not contain any induce-
ment to admission through for example a lighter sentence.  The arrestee may be given a cau-
tion, plus the opportunity or requirement to obtain advice and help from a drugs worker.
Meanwhile bail support allows the deferment of a final decision about charging while the
offender seeks help.  A needs analysis study undertaken by Merseyside Police of arrestees in
Southport, Huyton, Wavertree and St Helens custody suites found that 83% of those inter-
viewed admitted to taking drugs, of whom 23% were taking heroin and 11% methadone at
the time of arrest
14.  Research shows that ARS have a positive effect on drug use and property
offending with one study
15 showing falls in illicit opiate use (from 83% of arrestees to 55%) and
cocaine use (from 54% to 23%)
13.  Around 60% of individuals either stopped or reduced
property offending within nine months of the ARS contact.  Uptake of the ARS in Merseyside
and Cheshire will be monitored through the prevalence database and the Merseyside Inter
Agency Database (IAD).
Drug Treatment and Testing Orders (DTTO) are targeted at those offenders who com-
mit a high volume of crime to fund their drug taking activity and aim to reduce further offend-
ing.  The offender must undertake treatment which can be selected from a menu of options
including residential detoxification, rehabilitation, prescriptions, health education, lifestyle pack-
ages and offence focused work. Offenders are followed up with regular drug testing and review
by the sentencing court.  Three pilot schemes began in October 1998 in Liverpool, Croydon
and Gloucester.  DTTO is a voluntary scheme and participants must be carefully screened for
those who will obtain the most benefit from treatment and who have good motivation for
change.  The aim is for offenders to become drug free and to cease offending but how quickly
they attain drug free status may vary from scheme to scheme.  One pilot project required indi-
viduals to be drug free within two weeks.  Results of urine tests from the Liverpool DTTO15
supported self reports of drug consumption although other research
16 found evidence that
underreporting of drug use was substantial.  Furthermore, results of drug tests do not indicate
reductions in amount taken.  For example an individual may have considerably reduced the fre-
quency or quantity of drug taking without this being evident from a positive drugs test.  Self
reported drug taking and spending on drugs fell considerably (even at the first follow-up when
treatment was not well advanced) with average drug spending falling from £400 to £30 per
week per person and the average number of acquisitive crimes from 107 to 10
17.
Some individuals referred by DTTO have previously had contact with treatment services.  A
sample survey of those individuals reported by Liverpool DTTO to the Drug Monitoring Unit in
1998 and 1999, showed significant numbers who had previously been reported to the DMD as
having  prior service contact with other agencies from health and criminal justice service e.g. bail
support or prison
18.
Youth Offender Teams. There has been much public concern about increasing numbers of
young people being involved in drug taking and criminal activity and generally there have been
only low levels of services targeted at this group.  Youth Offender Teams were set up to deal
specifically with 10 to 17 year olds.  They aim, through the joint efforts of police, probation ser-
vice, social services, education departments and Health Authorities, to prevent offending by chil-
dren and young people and to act as a ‘gateway’ into other appropriate services, including drugs
services.  Pilot projects run in Sandwell, Derby and St Helens during 1997 and 1998
19, saw indi-
viduals aged mostly between 15 and 17 years of age, with some as young as 13.  The average
age of onset of drug use as low as 10 years of age.  These young people had high levels of drug
taking (including injecting) but did not see their drug use as a problem and few had been in con-
tact with treatment services.  A study of the Sandwell and Derby projects
20 found that there was
little drugs expertise or knowledge amongst many youth justice workers and this could lead to
the drug problems of young offenders being ignored.  In addition the study suggested that the
workers may perceive young offenders’ contact with drugs services as ‘drawing them into the
system’ and therefore likely to increase their drug activity.
Key Issues
The information provided by this report and the Merseyside Inter Agency Database can be used
to monitor the progress and success of the new policy initiatives.  In particular these data mea-
sure trends towards the achievement of key performance indicators and key performance tar-
gets from the Government’s drug strategy.  Numbers of drug users in contact with services indi-
cate progress on increasing numbers of offenders referred to and entering treatment from crimi-
nal justice service agencies (KPI 2 and KPT 2, see Boxes 1 and 2) . Some data in Table 1.1 begin
to measure referral from the criminal justice service into treatment (e.g. Liverpool Bail Support)
and such data will increase in future reports.  Information contained within Tables 1.2, 2.4, 2.5a,
2.5b, 3.2 and 3.4 provides measures of young (under 25 year old) drug users coming into con-
tact with services.  Equally, Tables 1.3, 1.4, 2.3, 3.3 and 4.3 provide indicators of the progress in
including female drug users in treatment (KPI 3).Outcomes of treatment are of vital importance in assessing the success of these new initiatives,
such as DTTO, ARS and YOTs, and Table 1.6 and 1.7 provide valuable data regarding treat-
ment outcomes.  The need for positive outcomes is highlighted in the 10 year strategy requiring
positive outcomes for people in treatment (KPI 2) and increased entry into treatment pro-
grammes which have positive health and crime impacts (KPI 3).  Data presented here include
analysis of numbers in receipt of methadone, drug free status, referrals to other services (and
the take up of those services) and the numbers who drop out of services.  For those who leave
services because they were drug free, monitoring of return to treatment provides indicators of
relapse and additional service demand.  Such analysis is provided in Table 1.8 and Figure 1.1
Furthermore, in combination with the Merseyside IAD, relapse back into the criminal justice
system can also be assessed.
As well as specialist treatment services, data in this report also allow monitoring of contact with
low threshold services. Tables 2.6a, 2.7 and 2.8 and Figures 2.2, 2.3a, 2.3b and 2.3c provide
such information for agency based syringe exchange services.  These can also be used as a
measure of those in treatment who still inject despite being in contact with specialist drugs ser-
vices, see Figure 5.1.  The same data can also independently measure changes in rates of hero-
in and cocaine use (KPT I) as well as reduction in injecting and sharing behaviour (KPI 3.2 ).
This report, in Tables 3.1 and 4.5, also provide the same information for those individuals in
contact with pharmacy based syringe exchange schemes and outreach services.
BOX TWO
First Annual Report and National Plan of the UKACDU: 
Key Performance Targets
KPT 1 Reduce the proportion of people under 25 reporting use of illegal drugs in 
the last month and previous year substantially and to reduce the proportion 
of  young people using the drugs which cause the greatest harm - heroin 
and cocaine - by 50% by 2008 (25% by 2005).
KPT 2 To reduce the levels of repeat offending amongst drug misusing offenders by 
50% by 2008 (25% by 2005).
KPT 3 To increase the participation of problem drug users, including prisoners in 
drug treatment programmes which have a positive impact on health and 
crime by 100% by 2008 (66% by 2005).
KPT 4 Reduce access to all drugs amongst young people (under 25) significantly,
and to reduce access to the drugs which cause the greatest harm, 
particularly heroin and cocaine, by 50% by 2008 (25% by 2005).
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Introduction
In order to assess progress in achieving the targets of the Government’s drugs strategy, to evalu-
ate current service provision and plan future service provision it is necessary to know the preva-
lence of presenting drug misuse. In particular, objective 3.4 requires knowledge of agency activity
and especially turnover of clients.  The data presented here, period prevalence data, in combi-
nation with data from the Drug Misuse Database (DMD), show that many agencies have a low
turnover, with clients staying in long term treatment, and returning to treatment after drug free
discharge.  This effectively means services are full and may prevent new clients from entering
treatment (see Tables 1.1 and 1.8 ).  The inclusion of outcome measures within period preva-
lence data gives a clear indication of patterns of movement of problem drug users through ser-
vices.  Other functions provided by period prevalence data are measurement of agency activity,
assessing the numbers receiving methadone, auditing agency reporting of episodes and the pro-
vision of additional research data.  
Period prevalence data are collected from specialist drug services (Community Drug Teams, in-
patient and out-patient services etc) in Merseyside and Cheshire.  Two new agencies began
reporting data in 1999, the Dual Action Response Team (DART), a dual diagnosis (severe mental
illness and drug or alcohol problems) based in South Cheshire and Liverpool Bail Support which
provides drug misuse treatment for individuals who are remanded on bail, and is run by
Merseyside Drugs Council.  Appendix III provides a list of all contributing agencies.
DEFINITIONS
User A person who visits an SDS at least once during the reporting period
(1999).
Double Counting When a person who visits more than one agency in Merseyside and 
Cheshire or within a Health Authority is counted at each agency or 
Health Authority.
Single Counting When a person who visits more than one agency in Merseyside and 
Cheshire or within a Health Authority is counted in only one (the last
they visited).
Supra District Agency (SDA) An agency which accepts clients from a wide geographical 
area.19
Individuals may have visited more than one agency within the Merseyside and Cheshire area
during 1999, potentially giving rise to double counting.  In Section one, double counting has
been excluded, using the attributor data of initials, date of birth and sex, and throughout the
analysis individuals are counted only once, at the last visit during the year (giving the most recent
outcome measure for each individual).  The only exception to this is in Table 1.1 where double
counting is included for comparison.
Table 1.1 Number of Users in Contact with Specialist Drug Services in 1999 by Reporting Agency
Agency Single Double  DMD 
Counted Counted Report
ARCH Initiatives  277 (  3.6%)  566 (  6.3%)  188 (  7.2%)
ARCH Initiatives, Residential  47 (  0.6%)  49 (  0.5%)  9 (  0.3%)
Chester CDT  439 (  5.6%)  524 (  5.9%)  141 (  5.4%)
Dual Action Response Team 18 (  0.2%) 18 (  0.2%) 24 (  0.9%)
Halton CDT  252 (  3.2%)  260 (  2.9%)  64 (  2.4%)
Integrated Care Team  120 (  1.5%)  122 (  1.4%)  25 (  1.0%)
The Kevin White Unit  192 (  2.5%)  192 (  2.1%)  183 (  7.0%)
Kirkby CDT  210 (  2.7%)  222 (  2.5%)  23 (  0.9%)
Lifeline, Warrington  38 (  0.5%)  38 (  0.4%)  21 (  0.8%)
Liverpool Bail Support  45 (  0.6%)  51 (  0.6%)  76 (  2.9%)
Liverpool DDU     924 (11.9%)  1,052 (11.8%)  257 (  9.8%)
Liverpool MDC  372 (  4.8%)  436 (  4.9%)  250 (  9.5%)
Macclesfield CDT  393 (  5.1%)  454 (  5.1%)  159 (  6.0%)
Newton-Le-Willows CDT  106 (  1.4%)  116 (  1.3%)  42 (  1.6%)
North Liverpool CDT  334 (  4.3%)  357 (  4.0%)  4 (  0.2%)
The Oakmere Unit  2 (  0.0%)  2 (  0.0%)  5 (  0.2%) 
Phoenix House  198 (  2.5%)  206 (  2.3%)  105 (  4.0%)
SHADO  64 (  0.8%)  66 (  0.7%)  113 (  4.3%)
South Cheshire CDT  278 (  3.6%)  307 (  3.4%)  143 (  5.4%)
South Knowsley CDT  204 (  2.6%)  239 (  2.7%)  90 (  3.4%)
South Sefton CDT  463 (  6.0%)  488 (  5.5%)  109 (  4.1%)
Southport DDU  133 (  1.7%)  148 (  1.7%)  15 (  0.6%)
Southport MDC  120 (  1.5%)  126 (  1.4%)  46 (  1.7%)
St Helens CDT  373 (  4.8%)  439 (  4.9%)  139 (  5.3%)
Turning Point 18 (  0.2%) 19 (  0.2%) 9 (  0.3%)
U-Turn Project  313 (  4.0%)  324 (  3.6%)  0 (  0.0%)
Warrington CDT                                   343 (  4.4%) 359 ( 4.0%) 134 ( 5.1%)
Wirral Drugs Service  1,496 (19.2%)  1,754 (19.6%)  255 ( 9.7%)
Total (100%)  7,772     8,934  2,629
CDT = Community Drugs Team   MDC = Merseyside Drugs Council  DDU = Drug Dependency Unit  DMD = Drug Misuse Database
* The column headed ‘Double Counted’ gives the number of individuals who contacted each agency during the year whilst the column headed ‘Single
Counted’ counts those individuals who visited more than one agency at only the last agency they visited.20
Altogether, 7,772 individuals were in contact with Merseyside and Cheshire agencies.  The
equivalent of 1,162 individuals (15.0%) visited more than one service during the year (see
Table 1.1).  This is a 0.8% decrease on 1998 and a 12.0% increase from 1997.  Although
two new agencies began reporting data in 1999 (Dual Action Response Team and Liverpool
Bail Support), these only accounted for 69 agency reports or 63 individuals.  The majority of agencies
reported similar numbers in 1999 as in 1998, however Liverpool DDU, U-Turn and Halton CDT
all reported greater numbers of individuals than in 1998 and numbers at U-Turn, an arrest referral
scheme, have more than doubled since 1997 (from 134 individuals to 313 in 1999), of whom only
11 had previously been in contact with local services.  This can be seen as a positive step towards 
KPI 2.1 to increase referrals from the criminal justice system into treatment programmes.
Most agencies reported a majority of individuals (nearly 90%) who had not visited another
agency earlier in the year and a few reported only individuals who had had not been seen by
other agencies.  These were the Dual Action Response Team (DART), The Kevin White Unit,
Lifeline and The Oakmere Unit.  Referrals to DART which is a dual diagnosis (severe mental ill-
ness and drug or alcohol problems) service based in South Cheshire come solely from psychi-
atric consultants and so it is likely that these individuals may represent a new population of drug
misusers entering treatment, in line with KPI 3 (see Box 1).  Individuals reported by the Kevin
White Unit, Lifeline and the Oakmere Unit could be new to services i.e. self referrals who have
had no contact with another agency, or they may have been referred by a GP (GPs do not
provide period prevalence data), an agency outside of Merseyside and Cheshire, or in a previ-
ous reporting year.  At the other end of the scale, one agency (ARCH Initiatives) reported 51%
of clients who had contacted another agency earlier in the year.  However ARCH Initiatives is
the target service of much referral in Wirral, especially from the Arrest Referral Service (U-
Turn).
The final column of Table 1.1 shows the number of reports to the DMD made by each agency.
It indicates the degree to which the DMD under estimates agency activity, particularly at those
agencies where treatment is based on long term maintenance treatment.  Agencies may have
different aims, for example, stabilisation through long term prescribing, short to medium term
detoxification etc, and will therefore attract different types of clients who will exhibit differing
patterns of  service contact.  Agencies with a focus on long term treatment will exhibit low
turnover, i.e. the number of DMD reports will be considerably lower than the number of
clients reported to be in contact.  For example, Wirral Drug Service and Southport DDU 
reported less than 15% of their clients to the DMD.  Without further investment in these
services, low turn over may lead to long waiting lists, a factor in contrast with Government
strategy which lays emphasis on the need for immediate access to appropriate services (KPI
3.4).  Conversely, those services whose focus is shorter term contact, for example detoxifica-
tion, are likely to exhibit high turn over with all or nearly all of their clients representing new
agency episodes and therefore being reported to the DMD.  For example, the Kevin White
Unit, a residential service, reported 95.3% of clients to the DMD and also reported 100% of
their clients as having been discharged drug free (see Table 1.7).  
Three agencies have produced anomalous figures: Liverpool Bail Support, the Oakmere Unit
and SHADO all show more individuals reported to the DMD than to period prevalence.  For
SHADO and Liverpool Bail Support, this is because they were only able to provide period
prevalence data for the second half of 1999 even though they were reporting to the DMD ear-
lier.  For the Oakmere Unit individuals reported to the prevalence database were incomplete.
Both sex and date of birth were recorded for 95.8% of all individuals reported by SDS andTable 1.2 shows the sex and age distribution of these individuals.  Overall 5,121 males were in
contact with services during 1999, representing 68.7 % of all clients and giving a female to male
ratio of 1:2.2, as in 1998.  This represents a greater proportion of females overall than either
agency based syringe exchange schemes (SES) who reported a female to male ratio of 1:6.0
or pharmacy based syringe exchange schemes (Pharmacy) who reported a female to male ratio
of 1:3.9.  Outreach services saw more females than males, (female to male ratio 1:0.5).  For
SDS, although the proportion of females has risen slightly against 1996 and 1997 when two
and a half males were reported for every female, these figures indicate that women are as yet
not being attracted into SDS in significantly greater numbers.
Table 1.2 Number of Users in Contact with Specialist Drug Services in 1999 by Sex and Age
Sex Total
Age Group Female Male
Under 15  4 (  0.2%)  5 (  0.1%)   9 (  0.1%)
15 - 19  85 (  3.6%)  115 (  2.2%)  200 (  2.7%)
20 - 24  351 (15.0%)  514 (10.0%)  865 (11.6%)
25 - 29  672 (28.8%)  1,273 (24.9%)  1,945 (26.1%)
30 - 34  691 (29.6%)  1,627 (31.8%)  2,318 (31.1%)
35 - 39  339 (14.5%)     976 (19.1%)  1,315 (17.6%)
40 - 44  102 (  4.4%)  336 (  6.6%)  438 (  5.9%)
45 - 49  60 (  2.6%)  169 (  3.3%)  229 (  3.1%)
Over 50  30 (  1.3%)  106 (  2.1%)  136 (  1.8%)
Total  (100%) 2,334   5,121 7,455
Data exclude all double counting i.e. each individual is only counted once, at the last agency they attended.
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Table 1.3 Number of Users in Contact with Specialist Drug Services in 1999 by Sex and 
Health Authority of Reporting Agency
Sex                                                  Total 
Health Authority                                Female                                             Male                         (100%)
Liverpool     716  (36.3%)  1,255 (63.7%)  1,971
North Cheshire 179 (28.2%) 455 (71.8%) 634
Sefton  265  (35.6%)  480 (64.4%)     745
South Cheshire  320 (28.2%)  814 (71.8%)  1,134
St Helens & Knowsley  265 (28.8%)  655 (71.2%)     920
Wirral 612 (28.4%) 1,546 (71.6%) 2,158
SDA*  146 (30.7%)  329 (69.3%)  475
Total                       2,503 (31.1%)                     5,534  (68.8%)              8,037
Double counting is excluded within Health Authorities i.e. an individual will be reported at only one agency they visited in each Health Authority.
*SDA = Supra District AgencyThe most common age range overall, for males and for females was 30 to 34 followed by 25
to 29.  Thus, SDS clients are the oldest group reported to the Drug Monitoring Unit as both
SES and Pharmacies reported 25 to 29 as the most common age group for both sexes.  Age of
individuals reported by outreach services (Outreach) is not currently recorded.  Female SDS
clients, however, were slightly younger than their male counterparts, with 18.8% aged under
25 (the age range targeted in Government strategy) compared to 12.3% of males.  This repre-
sents a fall in the numbers of young people reported (14.4%, overall, in 1999 compared to
17.0%  or over in each of the previous two years).  
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Table 1.4 Number of Users in Contact with Specialist Drug Services in 1999 by Sex and
Reporting Agency
Sex
Agency  Female  Male
ARCH Initiatives 81  (29.8%) 191  (70.2%)
ARCH Initiatives, Residential 13  (27.7%) 34 (72.3%)
Chester CDT 111  (25.4%) 326  (74.6%)   
Dual Action Response Team (DART) 3 (16.7%) 15  (83.3%)
Halton CDT 62  (24.7%) 189  (75.3%)
Integrated Care Team 45  (37.5%) 75  (62.5%)
The Kevin White Unit 69  (35.9%) 123  (64.1%)
Kirkby CDT 64   (30.5%) 146 (69.5%)
Lifeline, Warrington 12  (31.6%) 26  (68.4%)
Liverpool Bail Support 17  (37.8%) 28  (62.2%)
Liverpool DDU  349 (37.8%)   575 (62.2%)
Liverpool MDC  110 (29.6%)  262 (70.4%)
Macclesfield CDT 120  (30.5%) 273  (69.5%)
Newton-le-Willows CDT 48  (45.3%) 58  (54.7%)
North Liverpool CDT  120 (35.9%)  214 (64.1%)
The Oakmere Unit 1 (50.0%) 1 (50.0%)
Phoenix House 55  (27.8%) 143  (72.2%)
SHADO 38  (59.4%) 26  (40.6%)
South Cheshire CDT 83 (29.9%) 195  (70.1%)
South Knowsley CDT 50  (24.5%) 154  (75.5%)
South Sefton CDT  164 (35.4%)  299 (64.6%)
Southport DDU 57  (42.9%) 76  (57.1%)
Southport MDC 34  (28.6%) 85  (71.4%)
St Helens CDT 96  (25.8%) 276  (74.2%)
Turning Point 5 (27.8%) 13  (72.2%)
U-Turn Project 49  (15.7%) 263  (84.3%)
Warrington CDT 104  (30.5%) 237 (69.5%)
Wirral Drugs Service 462  (30.9%) 1,033  (69.1%)
Total (100%)   2,422   (31.2%)                                        5,336   (68.8%)
Data exclude double counting i.e. individuals are counted at only the last agencies they attended during 1999
CDT = Community Drugs Team MDC = Merseyside Drugs Council DDU = Drug Dependency UnitTable 1.3 shows the sex profile of SDS clients, which was broadly similar across all six Health
Authorities at around a third female.  Proportions of females reported by each Health Authority
have changed little since 1997 with Liverpool and Sefton Health Authorities reporting slightly
higher proportions of females (36.3% and 35.6%, respectively in 1999) than other Health
Authorities.  Supra District Agencies, which are typically residential units, have been reported
separately as they may take clients from any Health Authority, including those outside
Merseyside and Cheshire.
As in 1998, the majority of agencies reported between 25% and 35% of clients as female, and
the distribution patterns were similar over both years.  Newton-le-Willows CDT (which has
constructive links with a local maternity hospital) and SHADO (a family based service) both
reported considerably higher proportions of females (45.3% and 59.4%, respectively) see Table
1.4.  Although the Oakmere Unit reported 50.0% females only two individuals had been
reported.   Both DART and the U-Turn project reported less than a fifth of their clients as
female (16.7% and 15.7%, respectively).  DART clients are referred from psychiatric consul-
tants and so there is no obvious reason for a low rate of female attendance.  However this is a
new service (from autumn 1999) and future trends will be observed.  The U-Turn Project is an
Arrest Referral scheme.  Offenders in the criminal justice system are predominantly male
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Thus, for example, of all individuals arrested for drug crime in Merseyside in the second half of
1998 only 7.4% were female
22 and this could explain the low proportions of female clients at
the U-Turn project.
Table 1.5 Number of Users in Contact with Specialist Drug Services by Health Authority of 
Reporting Agency and Health Authority of Residence
Health Authority of Reporting Agency
Health Authority of  Liverpool North  Sefton South  St Helens
Residence Cheshire Cheshire & Knowsley Wirral SDA* Total
Liverpool  1,837  2  16  36  26  116  2,033
North Cheshire  4  402  2  2  3  1  414
Sefton  38  2     719  3  3  34     799
South Cheshire  1  12  1,119  44  24  1,200
St Helens & Knowsley  17  10  832  3  40     902
Wirral  3  2      2,019  65  2,089
North West (Other)  1  1      1  69  72
London  3  3
Northern & Yorkshire  1      13  14
South East 1 1
South West  1 1
Trent 1 5 6
West Midlands  1  3  1  17  22
Wales  2  1  4  7
Scotland                                                                                           1                                                    7 8
No Fixed Abode  1  1  14  16
Total 1,901 431   736 1,130  874  2,101  414 7,587
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be shown at the last
agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be represented in both Health Authorities. 
*SDA = Supra District AgencyTable 1.5 shows the Health Authority of residence of individuals in contact with specialist drug
services by the Health Authority of the reporting agency.  Supra-district agencies (SDA) take
clients from a wide range of areas and so they have been reported separately.  The majority of
individuals attended agencies within their Health Authority of residence, however 229 (3.2% of
those for whom residence was known and who visited non-SDA agencies) crossed into other,
mostly neighbouring Health Authorities within Merseyside and Cheshire.  A total of three indi-
viduals travelling from other North West Health Authorities, seven from other parts of England,
one from Scotland and three from Wales were reported by Merseyside and Cheshire non-SDA
agencies.  SDA agencies (those agencies which receive clients from a wide geographical area
and are ARCH initiatives residential service, The Oakmere Unit, Phoenix House and Turning
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Table 1.6 Number of Users in Contact with Specialist Drug Services in 1999 by Outcome Type
Outcome Type
Agency Active Non active
ARCH Initiatives 471  (  83.5%) 93  (  16.5%)
ARCH Initiatives, Residential 19  (  38.8%) 30  (  61.2%)
Chester CDT 511  (  97.7%) 12 (    2.3%)
Dual Action Response Team 15  (  83.3%) 3 (  16.7%)
Halton CDT 152  (  58.7%) 107  (  41.3%)
Integrated Care Team 104  (  85.2%) 18  (  14.8%)
The Kevin White Unit 0 (    0.0%) 191  (100.0%)
Kirkby CDT  171 (  77.0%)  51 (  23.0%)
Lifeline, Warrington 6 (  15.8%) 32  (  84.2%)
Liverpool Bail Support 11  (  21.6%) 40  (  78.4%)
Liverpool DDU  791 ( 75.2%) 261 ( 24.8%)
Liverpool MDC 164 (  38.0%)               268  ( 62.0%)
Macclesfield CDT 323  (  71.3%) 130  (  28.7%)
Newton-le-Willows CDT 93  (  80.2%) 23  (  19.8%)
North Liverpool CDT  291 (  81.5%)  66 (  18.5%)
The Oakmere Unit 0 (    0.0%) 1 (100.0%)
Phoenix House 79  (  38.3%) 127  (  61.7%)
SHADO 54  (  91.5%) 5 (    8.5%)
South Cheshire CDT 219  (  71.3%) 88  (  28.7%)
South Knowsley CDT 196  (  82.4%) 42  (  17.6%)
South Sefton CDT  402 (  82.4%)  86 (  17.6%)
Southport DDU 127  (  85.8%) 21  (  14.2%)
Southport MDC 69  (  55.2%) 56  (  44.8%)
St Helens CDT 345  (  78.9%) 92  (  21.1%)
Turning Point 4 (  21.1%) 15  (  78.9%)
U-Turn Project 228  (100.0%) 0 (    0.0%)
Warrington CDT 279  (  77.7%) 80  (  22.3%)
Wirral Drugs Service 1,517  (  86.5%) 236 (  13.5%)
Total (100%)  6,641    (75.3%)                                          2,174 ( 24.7%)
Data include double counting i.e. individuals are counted at all agencies they attended during 1999
CDT = Community Drugs TeamMDC = Merseyside Drugs Council DDU = Drug Dependency Unit25
Point) had a much wider catchment with 69 clients from other North West areas, 40 from
other parts of England, four from Wales and seven from Scotland.  The figures are very similar to
those in 1998, although marginally more individuals have been reported from outside the North
West region in 1999.  This may be the result of improved data rather than a sudden influx of 
individuals from other areas.  Only 16 individuals were reported as having no fixed abode in 1999.
There are a number of possible reasons for such a low figure: for instance, those who have no
permanent or temporary address may not wish to have this recorded.  Alternatively those of
no fixed abode may not perceive drugs services as being appropriate to their needs or be willing
to enter them for treatment.
Table 1.6 shows the numbers of users for whom outcome type was recorded.  Active out-
comes are those where the client is still in contact with the agency at the end of the reporting
period (1999).  Active clients may be: in receipt of a methadone prescription; in receipt of
another prescription or not receiving any prescription.  Non active clients may be: discharged
drug free; referred to another agency; lost to prison; dead; lost to follow-up.  One service (U-
Turn) recorded that 100% of clients were still active, however, these are clients recently
referred from the criminal justice system embarking on treatment.  The Kevin White Unit
reported no ‘active’ clients, because the end of the reporting period (December 31, 1999)
coincides with their Christmas ‘close-down’ and therefore all clients have been discharged.
Outcome was recorded for 98.6% of the 8,934 (double counted) individuals reported by SDS
in Merseyside and Cheshire in 1999 and the proportion of service clients who were ‘active’ at
the end of the reporting year has been rising steadily from 59.0% in 1996 to 75.3% in 1999.
As in previous years there is considerable variation between agencies in the proportions of
active and non active clients reported.  Apart from agencies discussed above, these differences
may reflect the different aims of different services.  Residential units (ARCH, Phoenix House and
Turning Point) reported lower proportions of ‘active’ clients because their treatment pro-
grammes are aimed at time limited detoxification of drug users rather than long term stabilisa-
tion.   Chester CDT, SHADO and Wirral Drug Service all reported high proportions of their  
clients as still active, reflecting the longer term nature of treatment interventions at these agencies.
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Table 1.7 shows the outcome profiles of clients of individual agencies in Merseyside and
Cheshire.  Outcomes of treatment episode are important to the measurement of the
Government’s drug strategy, measuring, for example, the success of detoxification programmes
(discharged drug free) continued provision of substitute prescribing, repeat offending etc.  As in
1998, nearly two thirds of users (61.3%) were in receipt of methadone, a rise from 58.6% in 1997.
For 1999, those in receipt of a methadone prescription at the end of the year represent 81.3%
of all ‘active’ users.  Amongst non-active clients, a greater proportion were reported as having
left services drug free than any other category. However, the actual rate has fallen from 19.3%
in 1997 to 9.4% in 1999.  This equates to 38.0% of non-active individuals.  Although this may
Table 1.7 Number of Users in Contact with Specialist Drug Services in 1999 by Outcome and 
ARCH Initiatives
1 59 (10.5%) 8 (  1.4%) 404  (71.6%) 0 (  0.0%)
ARCH Initiatives
2 0 (  0.0%) 0 (  0.0%) 19  (38.8%) 1 (  2.0%)
Chester CDT 427     (81.6%) 44   (  8.4%) 40  (  7.6%) 0 (  0.0%)
DART
3 (Cheshire) 0 (  0.0%) 0 (  0.0%) 15  (83.3%) 0 (  0.0%)
Halton CDT 132      (51.0%) 20   (  7.7%) 0 (  0.0%) 14  (  5.4%)
Integrated Care Team 104     (85.2%) 0 (  0.0%) 0 (  0.0%) 2 (  1.6%)
The Kevin White Unit 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%)
Kirkby CDT  171    (77.0%)  0  (  0.0%)  0  (  0.0%)  10 (  4.5%)
Lifeline, Warrington 0 (  0.0%) 0 (  0.0%) 6 (15.8%) 1 (  2.6%)
Liverpool Bail Support 6 (11.8%) 0 (  0.0%) 5 (  9.8%) 4 (  7.8%)
Liverpool DDU     791     (75.2%)  0  (  0.0%)  0  (  0.0%)  13 (  1.2%)
Liverpool MDC 71      (16.4%) 0 (  0.0%) 93  (21.5%) 12  (  2.8%)
Macclesfield CDT 248      (54.7%) 46   (10.2%) 29 (  6.4%) 7 (  1.5%)
Newton-Le-Willows CDT 84     (72.4%) 0 (  0.0%) 9 (  7.8%) 2 (  1.7%)
North Liverpool CDT  291     (81.5%)  0  (  0.0%)  0  (  0.0%)  4  (  1.1%)
The Oakmere Unit 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%)
Phoenix House 0 (  0.0%) 0 (  0.0%) 79  (38.3%) 0 (  0.0%)
SHADO 30      (50.8%) 0 (  0.0%) 24  (40.7%) 0 (  0.0%)
South Cheshire CDT 194      (63.2%) 5 (  1.6%) 20  (  6.5%) 18  (  5.9%)
South Knowsley CDT 189      (79.4%) 0 (  0.0%) 7 (  2.9%) 5 (  2.1%)
South Sefton CDT  402     (82.4%)  0  (  0.0%)  0  (  0.0%)  6  (  1.2%)
Southport DDU 127      (85.8%) 0 (  0.0%) 0 (  0.0%) 4 (  2.7%)
Southport MDC 4 (  3.2%) 3 (  2.4%) 62  (49 6%) 0 (  0.0%)
St Helen’s CDT 344      (78.7%) 0 (  0.0%) 1 (  0.2%) 6 (  1.4%)
Turning Point 0 (  0.0%) 0 (  0.0%) 4 (21.1%) 3 (15.8%)
U-Turn Project 27      (11.8%) 11   (  4.8%) 190 (83.3%) 0 (  0.0%)
Warrington CDT 232     (64.6%) 12   (  3.3%) 35  (  9.7%) 0 (  0.0%)
Wirral Drugs Service 1,467     (83.7%) 24   (  1.4%) 26  (  1.5%) 28  (  1.6%)
Total (100%)  5,400  (61.3%) 173  (  2.0%) 1,068   (12.1%)      140 (1.6%)
Data include double counting i.e. individuals are counted at all agencies they attended during 1999 
ARCH Initiative
1 =Non-residential.  ARCH Initiative
2 = Residential DART
3=Dual Action Response Team. CDT = Community Drugs Team.                                                    
Agency                                                Methadone                 Other 'Script'                     No 'Script' Lost to Prison
Prescription 
Active27
seem low, it does reflect the aims of many services i.e. to achieve long term stabilisation
through substitute prescribing rather than detoxification.  Those agencies whose aim is short-
term detoxification/rehabilitation are likely to have a much higher discharged/drug free rate than
those whose aim is for longer term stabilisation.  For example Phoenix House reported 48.5%
as drug free.  ARCH Residential services reported just 24.5% drug free, but a further 24.5%
were referred to other services, which could include referral on for post-detoxification services.
The Kevin White Unit reported 100% non-active clients and all were reported as being drug
free upon discharge.  The majority of other outcomes have been reported at a steady rate over
the last three years with only the proportions of individuals who were active but not in receipt
of a methadone prescription changing significantly (from 6.8% in 1997 to 14.1% in 1999).
Reporting Agency
14  (  2.5%) 16 (  2.8%) 0 (  0.0%) 58  (10.3%) 5 (  0.9%) 564
12 (24.5%) 12 (24.5%) 1 (  2.0%) 3 (  6.1%) 1 (  2.0%) 49
11  (  2.1%) 0 (  0.0%) 1 (  0.2%) 0 (  0.0%) 0 (  0.0%) 523
0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 3 (16.7%) 18 
80  (30.9%) 10  (  3.9%) 1 (  0.4%) 0 (  0.0%) 2 (  0.8%) 259
6 (  4.9%) 3 (  2.5%) 1 (  0.8%) 6 (  4.9%) 0 (  0.0%) 122
191 (100.0%)  0  (  0.0%)  0  (  0.0%)  0  (  0.0%)  0  (  0.0%)  191
5  (  2.3%)    9  (  4.1%)  0  (  0.0%)  21 (  9.5%)  6  (  2.7%)  222
3  (  7.9%)  1  (  2.6%)  0  (  0.0%)  15 (39.5%)  12  (31.6%)  38
0 (  0.0%) 11 (21.6%) 0 (  0.0%) 0 (  0.0%) 25 (49.0%)             51
25 (  2.4%)  22  (  2.1%)  2  (  0.2%)  160 (15.2%)  39  (  3.7%)  1,052
108 (25.0%)  60 (13.9%)  1  (  0.2%)  79 (18.3%)  8  (  1.9%)  432
68 (15.0%)  11 (  2.4%)  0  (  0.0%)  43 (  9.5%)  1  (  0.2%)  453
14 (12.1%)  4  (  3.4%)  0  (  0.0%)  0  (  0.0%)  3  (  2.6%)  116
8  (  2.2%)  8  (  2.2%)  0  (  0.0%)  45 (12.6%)  1  (  0.3%)  357
0  (  0.0%)  0  (  0.0%)  0  (  0.0%)  1  (100.0%)  0  (  0.0%)  1
100 (48.5%)  2  (  1.0%)  1  (  0.5%)  20 (  9.7%)  4  (  1.9%)  206
2  ( 3.4%)  0  (  0.0%)  0  (  0.0%)  0  (  0.0%)  3  (  5.1%)  59
15 (  4.9%)  3  (  1.0%)  0  (  0.0%)  16 (  5.2%)  36  (11.7%)  307
1  (  0.4%)  4  (  1.7%)  0  (  0.0%)  20  (  8.4%)  12  (  5.0%)  238
17  (  3.5%)  5  (  1.0%)  1  (  0.2%)  53 (10.9%)  4  (  0.8%)  488
5 (  3.4%) 2 (  1.4%) 1 (  0.7%) 8 (  5.4%) 1 (  0.7%) 148
8 (  6.4%) 11  (  8.8%) 1 (  0.8%) 35  (28.0%) 1 (  0.8%) 125
13  (  3.0%) 2 (  0.5%) 0 (  0.0%) 46  (10.5%) 25  (  5.7%) 437
2 (10.5%) 3 (15.8%) 0 (  0.0%) 1 (  5.3%) 6 (31.6%) 19
0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 228
78  (21.7%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 2 (  0.6%) 359
41 (  2.3%) 64 (  3.7%) 6 (  0.3%) 97  (  5.5%) 0 (  0.0%) 1,753
827  (  9.4%)  263  ( 3.0%)             17    ( 0.2%)          727    ( 8.2%)        200   ( 2.3%)    8,815
                            DDU = Drug Dependency Unit   MDC = Merseyside Drugs Council 
Discharged /               Referred to                    Known Dead                   Lost to                      Non active                 Total
Drug Free                Other Agency                                                      Follow Up                     (Other)                
Non-Active28
Plate 1 Population Rates per 1,000 Residents for Drug Users in Contact with Specialist
Drug Services in 1999 by Postal Area of Residence
Plate 1 shows the area of residence of users who attended specialist drug services in 1999.  The rates
shown are the number of male 15 to 44 year old users per 1,000 male 15 to 44 year old residents in
each postal area.29
Plate 2 Population Rates per 1,000 Residents for Drug Users Reported by Pharmacy
Based Syringe Exchange Schemes in 1999 by Postal Area of Residence
Plate 2 shows the area of residence of users who attended pharmacy based Syringe Exchange Schemes in
Merseyside and Cheshire in 1999. The rates shown are the number of male 15 to 44 year old users per
1,000 male residents aged between 15 and 44 in each postal area.30
Plate 3 Population Rates per 1,000 Residents for Drug Users Reported by Agency Based
Syringe Exchange Schemes in 1999 by Postal Area of Residence
Plate 3 shows the area of residence of users who attended agency based Syringe Exchange Schemes in
Merseyside and Cheshire in 1999.  The rates shown are the number of male 15 to 44 year old users per
1,000 male residents aged between 15 and 44 in each postal area.31
Agency Based SES Outreach Services
Pharmacy Based SES Specialist Drug Services
Plate 4 Population Rates per 1,000 Residents for Drug Users in Contact with Agency Based
Syringe Exchange Schemes, Outreach, Pharmacy Based Syringe Exchange Schemes and Specialist
Drug Services in 1999 By Health Authority
Plate 4 shows the population rates of individuals who were in contact with each of the agency types by
Health Authority.  Rates for Outreach Services are the number of male users per 1,000 male 
residents.  For all other services the rates are for males aged between 15 and 44.32
Figure 1.1 shows trends in the percentages of all users reported by SDS in 1997, 1998 and 1999
who were discharged drug free as a percentage of all users reported.  In 1997 Wirral Drug
Services reported over a third (37.7%) of all their clients as having been discharged drug free.
Supra district agencies (those agencies which accept clients from a wider geographical area than
their own Health Authority) reported generally higher percentages of clients discharged drug free
than did the Health Authorities (with the exception of Wirral in 1997).  This is because SDA agen-
cies are generally residential detox. / rehabilitation agencies, where clients would normally be
expected to attain drug free status.
Table 1.8 is new for 1999 and shows the numbers of individuals discharged drug free in 1997 and
1998 and who re-presented to services in 1998 and 1999.  While this does not represent all indi-
viduals who relapse (some may present to services outside Merseyside and Cheshire while others
may not present at all) the table does show the previously unidentified level of service demand
from relapsed drug free clients in Merseyside and Cheshire.  Being discharged from a service drug
free clearly does not guarantee continued drug free status and some research has suggest that
relapse rates can be between 50% and 97% within a year of discharge from detoxification ser-
vices
23,24.  Of those 1,284 individuals who were discharged drug free in 1997, 402 (31%) re-con-
tacted services in 1998 and a further (33%) also re-contacted services in 1999.  In other words, by
the end of 1999, 40% of those discharged drug free in 1997 had re-entered treatment.  In addi-
tion, 35% of those discharged drug free in 1998 entered treatment again in 1999.  Future reporting
will be carefully monitored to obtain revisiting rates for drug free clients over longer periods of
time.  Further research, including the cross-referencing of these data with data from needle
exchanges, Arrest Referral Schemes and other parts of the criminal justice systems may give more
accurate indications of relapse rates.
Table 1.8 Number of Individuals who were discharged drug free 1n 1997 and 1998 
who re-presented to services in 1999
Year Discharged Also seen in Also seen in Not seen Number Discharged
Drug Free 1998 1999 again Drug Free (100%)
1997  402 (31%)  419 (33%)  769 (60%)  1,284
1998  -  175 (35%)  319 (65%)  494
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Figure 1.1 All Users Discharged Drug Free by Health Authority in 1997, 1998, 1999
SDA = Supra district agencies33
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AGENCY BASED SYRINGE 
EXCHANGE SCHEMES
SECTION 234
Introduction
In 1999, as in the previous three years, all sixteen agency based syringe exchange schemes
(SES) in Merseyside and Cheshire reported data to the Drug Monitoring Unit.  However, clients
of Ellesmere Port CDT are shown as being in contact with the ‘parent’ service, Chester CDT
and data which were previously recorded as from Lifeline are now shown as Warrington CDT.
A full list of reporting agencies is given in Appendix III.  This section of the report presents data
about individuals who use these services, and the visits they made during 1999.  Using an attrib-
utor made up of initials, date of birth and sex, double counting has been removed from these
data i.e. an individual is counted only on their first visit in 1999 to any reporting agency.  Where
analysis is by Health Authority of reporting agency, individuals are reported only once in each
Health Authority but may be reported by more than one Health Authority.   All visits made by
each individual are included, either across Merseyside and Cheshire or within the Health
Authority as appropriate.  In this year’s report, crack has been analysed separately from cocaine
and whilst numbers of crack users in 1999 were small, this will allow the monitoring of trends of
a drug that some sources report is becoming more common.
The monitoring of non-treatment agencies, such as SES, helps to build a more complete picture
of the extent of presenting problem drug use and these data can be used in conjunction with
those from specialist drug services to provide a more accurate measurement of the objectives of
the Government’s drugs strategy, for example, numbers in treatment, young drug users, heroin
and cocaine use, injecting behaviour and the extent of sharing of injecting equipment.
Table 2.1 All Users, New Uses and Visits Reported by Agency Based Syringe Exchange 
1997  1998 
Health Authority All Users New Users Repeat Users Visits All Users New Users
Liverpool 965 (26.0%) 318  (21.1%) 647 (29.3%)          3,975 (23.4%) 1,035 (28.4%) 428 (32.4%)
North Cheshire 259 (  7.0%) 108 (7.2%) 151 (  6.8%) 812 (  4.8%) 326 (8.9%) 166 (12.6%)
Sefton 486 (13.1%) 336 (22.3%) 150 (  6.8%) 2,142 (12.6%) 449 (12.3%) 159 (12.0%)
South Cheshire 594 (16.0%) 217 (14.4%) 377 (17.1%) 2,293 (13.3%) 528 (14.5%) 167 (12.6%)
St Helens & Knowsley 730 (19.6%) 297 (19.6%) 433 (19.6%) 4,678 (27.6%) 766 (21.0%) 238 (18.0%)
Wirral 684 (18.4%) 232 (15.4%) 452 (20.5%) 3,078 (18.2%) 542 (14.9%) 164 (12.4%)
Total (100%)          3,718               1,508                  2,210   16,978                     3,646               1,322
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be shown at                       35
Table 2.1 shows the Health Authority profile of reported users.  Individuals are reported only
once in each Health Authority, but may be reported by more than one Health Authority.
During 1999, 3,620 individuals were reported by the sixteen agency based SES in Merseyside
and Cheshire.  Of these 30 individuals visited agencies in more than one Health Authority and
550 visited more than one agency in any Health Authority.  Forty one percent of users (1,487
individuals) were new to services in 1999, an increase on 1998 (37% of all users) but still
lower than in 1996 when 48% of all users were new to services.  A similar number of individ-
uals were reported in 1999 to 1998 (3,690 and 3,646 individuals, respectively) although the
distribution between new and repeat users has changed.  The number of new users has risen
by 13.5 % while the number of repeat users has dropped slightly (5.8%).  A total of 18,859
visits were made to SES during the year giving a visit rate (the average number of visits per per-
son) of 5.1 compared to 5.2 in 1998, 4.6 in 1997 and 4.9 in 1996.  Increased uptake of ser-
vice is a focus of the Government’s drug strategy and one measure of this is increased numbers
and proportions of new users.  On average Health Authorities reported around 40% of their
users as being new to services.  In contrast North Cheshire reported a greater proportion
(57.4%) of new users and Wirral a lower proportion (29.5%).  See also Figure 2.1 for trends
in numbers of new users between 1996 and 1999.
DEFINITIONS
User A person who visits an SES - they may be a new user or a repeat user.
New User A person visiting services for the first time.
Repeat User A person who visits an SES agency for the second or any subsequent time 
regardless of length of time between visits.
Visit When a person presents to an SES for the first or any subsequent time.
NB this is not the same as an episode reported to the Drug Misuse Database.
Visit Rate The number of visits divided by the number of users to give an average 
number of  visits made by each user.
Drug Any drug of misuse excluding tobacco and alcohol.  The main drug of 
misuse is recorded on first contact with services.
Double Counting When a person who visits more than one agency in Merseyside and Cheshire or 
within a Health Authority is counted at each agency or Health Authority.
Single Counting When a person who visits more than one agency in Merseyside and Cheshire or 
within a Health Authority is counted in only one (the first they visited).
Schemes in, 1997, 1998 and 1999 by Health Authority of Reporting Agency
1999
Repeat Users Visits All Users New Users Repeat Users Visits
607 (26.1%) 4,691 (24.8%) 1,010 (27.4%) 416 (27.7%) 594 (27.1%) 4,895 (26.0%)
160 (  6.9%) 1,168 (  6.2%) 352 (  9.5%) 202 (13.5%) 150 (  6.9%) 784 (  4.2%)
290 ( 12.5%) 2,134 (11.3%) 428 (11.6%) 171 (11.4%) 257 (11.7%) 1,974 (10.5%)
361 ( 15.5%) 2,100 (11.1%) 530 (14.4%) 216 (14.4%) 314 (14.3%) 1,936 (10.3%)
528 (22.7%) 5,687 (30.1%) 820 (22.2%) 333 (22.2%) 487 (22.2%) 6,318 (33.5%)
378 (16.3%) 3,136 (16.6%) 550 (14.9%) 162 (10.8%) 388 (17.7%) 2,952 (15.7%)
2,324  18,916 3,690   1,500   2,190                18,859
                    the first  agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be shown at both.36
Figure 2.1 shows the numbers of new users in contact with SES agencies in each Health
Authority in 1996, 1997, 1998 and 1999 and indicates the extent to which new clients are
being attracted into service contact; a key objective of the Government’s drug strategy.  The
numbers of new users attracted into services over the four reported years varies from Health
Authority to Health Authority, with both North Cheshire and St Helens and Knowsley agencies
reporting more new users in 1999 than in any other year, while Wirral, Liverpool and Sefton
saw less than in previous years.   It is unclear whether increasing numbers of SES clients repre-
sent rising populations of injecting drug users or the attraction of existing injectors into services.
However the use of SES by injecting drug users represents harm reduction behaviour, a specific
aim of the Government’s strategy to increase participation in programmes with health benefits.
Contacts with SES also increases access to information, advice and practical help for drug users
and may lead to engagement with treatment services.
Table 2.2 shows the agency profile of reported users in 1997, 1998 and 1999.  These figures
include double counting, i.e. individuals are reported at each agency they visited during the year.
Data from Ellesmere Port CDT,  have now been included with Chester CDT and Warrington
CDT data were previously recorded as Lifeline.  Agency activity was not available for 1996.
The overall proportion of users who were new to services was 42.7% with individual agencies
reporting between 33.5% (South Sefton CDT) and 67.2% (Halton CDT) of their users as new.
Table 2.2 All Users, New Users and Visits Reported by Agency Based Syringe Exchange                                  
Agency All Users New Users Visits All Users
Chester CDT 226 (  6.1%) 94 (  6.3%) 693 (  4.1%) 138 (  3.9%)
Halton CDT 110 (  3.0%) 51 (  3.4%) 297 (  1.7%) 141 (  4.0%)
Kirkby CDT 82 (  2.2%) 45 (  3.0%) 221 (  1.3%) 111 (  3.1%)
Macclesfield CDT 238 (  6.4%) 65 (  4.3%) 1,127 (  6.6%) 288 (  8.1%)
Maryland Centre 811 (21.8%) 318 (21.1%) 3,313 (19.5%) 896 (25.1%)
Newton-le-Willows  CDT 53 (  1.4%) 29 (  1.9%) 207 (  1.2%) 64 (  1.8%)
North Liverpool CDT 154 (  4.1%) 85 (  5.6%) 662 (  3.9%) 108 (  3.0%)
South Cheshire CDT 130 (  3.5%) 58 (  3.8%) 473 (  2.8%) 100 (  2.8%)
South Knowsley CDT 140 (  3.8%) 72 (  4.8%) 927 (  5.5%) 144 (  4.0%)
South Sefton CDT 166 (  4.5%) 54 (  3.6%) 661 (  3.9%) 145 (  4.1%)
South Sefton MDC 193 (  5.2%) 108 (  7.2%) 918 (  5.4%) 135 (  3.8%)
Southport MDC 127 (  3.4%) 44 (  2.9%) 563 (  3.3%) 155 (  4.3%)
St Helens CDT 455 (12.2%) 196 (13.0%) 3,323 (19.6%) 428 (12.0%)
Warrington CDT 149 (  4.0%) 57 (  3.8%) 515 (  3.0%) 177 (  5.0%)
Wirral HIV & AIDS Prevention 684 (18.4%) 232 (15.4%) 3,078 (18.1%) 535 (15.0%)
Total (100%) 3,718 1,508 16,978 3,565
Data include double counting i.e. individuals are counted at all agencies they attended during 1998
199737
                Schemes in 1997, 1998 and 1999 by Reporting Agency
New Users Visits All Users  New Users Visits
45 (  3.4%) 429 (  2.3%) 164 (  3.9%) 61 (  3.4%) 422 (  2.2%)
80 (  6.1%) 522 (  2.8%) 195 (  4.7%) 131 (  7.4%) 350 (  1.9%)
79 (  6.0%) 453 (  2.4%) 132 (  3.2%) 82 (  4.6%) 400 (  2.1%) 
79 (  6.0%) 1,321 (  7.0%) 304 (  7.3%) 126 (  7.1%) 1,131 (  6.0%)
390 (29.5%) 4,248 (22.5%) 969 (23.2%) 408 (22.9%) 4,550 (24.1%)
30 (  2.3%) 283 (  1.5%) 77 (  1.8%) 34 (  1.9%) 325 ( 1.7%)
38 (  2.9%) 443 (  2.3%) 126 (  3.0%) 51 (  2.9%) 345 (  1.8%) 
43 (  3.3%) 350 (  1.9%) 154 (  3.7%) 88 (  4.9%) 383 (  2.0%)
62 (  4.7%) 1,050 (  5.6%) 159 (  3.8%) 60 (  3.4%) 1,041 (  5.5%)
57 (  4.3%) 756 (  4.0%) 173 (  4.1%) 58 (  3.3%) 742 (  3.9%)
49 (  3.7%) 612 (  3.2%) 135 (  3.2%) 65 (  3.7%) 517 (  2.7%)
53 (  4.0%) 766 (  4.0%) 176 (  4.2%) 65 (  3.7%) 715 (  3.8%)
67 (  5.1%) 3,901 (20.6%) 569 (13.6%) 228 (12.8%) 4,552 (24.1%)
86 (  6.5%) 646 (  3.4%) 251 (  6.0%) 134 (  7.5%) 434 (  2.3%)
164 (12.4%) 3,136 (16.6%) 586 (14.1%) 189 (10.6%) 2,952 (15.7%)  
1,322  18,916 4,170 1,780 18,859
Fig 2.1
1998 1999
Figure 2.1 New Users Reported by Agency Based Syringe Exchange Schemes in 1996, 1997, 
1998 and 1999 by Health Authority of Reporting Agency
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1999Table 2.3 shows the sex profile of all and new users by Health Authority of reporting agency
and includes double counting of those individuals who visited SES in more than one Health
Authority.  Overall 3,069 males were in contact with SES during 1999, representing 85.7% of
clients and giving a female to male ratio of 1:6.0.  These figures almost exactly mirror those in
1998 (3077 males or 85.9% of all users and a female to male ratio of 1:6.0).  The female to
male ratio amongst new users was higher at one female for every 6.7 males.  These propor-
tions have remained static over the last three reporting years with the proportions of females
being 14.1% in 1998, 14.6% in 1997 and 14.3% in 1999.  
Pharmacies reported 20.2% of all users and 20.5% of new users as female; at SDS 31.3% of
users were female whilst at Outreach 65.6% (all users and new users) were female.  Women
are specifically targeted by the Government’s drug strategy and research
25 indicates that women
are significantly more likely to be the recipients of shared equipment than are men.  They are
therefore at greater potential risk of contracting blood borne infections. Further research is
needed to identify ways in which more females can be encouraged to into syringe exchange
services within both agencies and pharmacies.  As in 1998, North Cheshire and St Helens and
Knowsley saw particularly low proportions of females, less than 10% of clients.  A high propor-
tion of users (over half of all and new users, see Tables 2.7a and 2.7b) reporting anabolic
steroid use, were recorded in North Cheshire, which may account for the low proportion of
females.  SES within Liverpool Health Authority succeeded in more than doubling the propor-
tion of female clients, from only 7.7% in 1997 to 16.7% in 1999.
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Table 2.3 All Users and New Users Reported by Agency Based Syringe Exchange Schemes 
in 1999 by Sex and Health Authority of Reporting Agency
All Users New Users
Health Authority Female Male Female Male
Liverpool 167 (16.7%) 834  (83.3%) 61  (14.8%) 351  (85.2%)
North Cheshire 30  ( 9.1%) 299  (90.9%) 15  (  8.1%) 171  (91.9%)
Sefton 62  (14.6%) 363  (85.4%) 19  (11.1%) 152  (88.9%)
South Cheshire 92 (17.5%) 433  (82.5%) 40  (18.7%) 174  (81.3%)
St Helens & Knowsley 75  (  9.2%) 742  (90.8%) 27  (  8.1%) 305  (91.9%)
Wirral 93  (17.1%) 451 (82.9%) 29  (18.4%) 129  (81.6%)
Total 519 (14.3%) 3,122  (85.7%) 191 (13.0%) 1,282 (87.0%)
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be
shown at the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be shown at both.39
Table 2.4 shows the number and proportion of individuals by age and sex.  The most common
age range amongst all and new users overall was 25 to 29.  This represents the same age
group as clients of pharmacies with SDS clients being slightly older.  Female SES clients were
younger than their male counterparts being as likely to be aged between 30 to 34.
Table 2.5 shows the age and Health Authority breakdown of SES clients in 1999.  The majority
of Health Authorities reported 25 to 29 as the most common age for all and new users.
Between 28.6% and 34.1% of all users and 32.7% and 34.1% of new users were 25 to 29.
North Cheshire new users were slightly younger, being more likely to be aged 20 to 24
(29.1%) while Wirral clients were slightly older being more likely to be 30 to 34 (33.3% of all
users and 31.9% of new users).  
In both 1996 and 1997 new users in North Cheshire, South Cheshire, Liverpool and St
Helens and Knowsley were more likely to be between 20 and 24.  See Figure 2.2a and 2.2b
for proportions of all and new users under 25 years of age.
Government strategy targets young people including their access to appropriate services.  The
recent trend (1996 to 1998) however has been a reduction in the number of under 25 year
olds accessing SES.  From Figures 2.2a and 2.2b it appears that this decline has abated in 1999
with overall proportions of all and new users being slightly higher than in 1998.  However they
remain considerably below 1996 and 1997 rates.  Individual Health Authorities have mostly
reported higher proportions of young people, except Wirral where, the proportion has
dropped from 20.7% in 1996 to 9.7% in 1999.  However, the proportion of young, new
users in Wirral has risen from 15.4% in 1998 to 16.9% in 1999 although again this is still con-
siderably below 1996 and 1997 proportions (31.3% and 26.0%, respectively).  South
Cheshire reported significantly higher proportions of all and new young drug users (30.9% and
40.3% respectively, compared to the average of 21.5% and 30.1%).
Table 2.4 All Users, New Users and Visits Reported by Agency Based Syringe Exchange Schemes
in 1999 by Sex and Age
All Users New Users Visits
Age Group Female Male Female Male Female Male
Under 15 1 (  0.2%) 3 (  0.1%) 0 (  0.0%) 0 (  0.0%) 1 (  0.0%) 8 (  0.1%)
15 - 19 29 (  5.7%) 110 (  3.6%) 20 (10.7%) 78 (  6.3%) 123 (  5.1%) 336 ( 2.2%)
20 - 24 96 (18.9%) 510 (16.8%) 44 (23.5%) 296 (23.8%) 348 (14.3%) 1,736 (11.4%)
25 - 29 138 (27.1%) 951 (31.3%) 59 (31.6%) 401 (32 3%) 498 (20.5%) 4,506 (29.7%)
30 - 34 139 (27.3%) 781 (25.7%) 38 (20.3%) 267 (21.5%) 764 (31.5%) 3,876 (25.6%)
35 - 39 63 (12.4%) 415 (13.6%) 20 (10.7%) 130 (10.5%) 312 (12.9%) 2,803 (18.5%)
40 - 44 23 (  4.5%) 167 (  5.5%) 4 (  2.1%) 48 (  3.9%) 154 (  6.3%) 1,023 (  6.7%)
45 - 49 17 (  3.3%) 71 (  2.3%) 2 (  1.1%) 17 (  1.4%) 105 (  4.3%) 477 (  3.1%)
50 & Over 3 (  0.6%) 34 (  1.1%) 0 (  0.0%) 6 (  0.5%) 122 (  5.0%) 401 (  2.6%)
T otal (100%)      509                3,042 187 1,243 2,427 15,166Table 2.6a shows reported drug of use by all users, new users and visits. As in previous years,
the most commonly reported drug amongst users and new users was heroin (49.1% and
44.6%, respectively).  However, the proportions of new users reporting heroin were slightly
lower than in the previous two years (see Figure 2.3). Anabolic steroids (AS) were the second
most commonly reported drug having risen, from 25.1% of all users in 1998 to 28.3% in 1999
and from 33.6% of new users to 37.4%.  Methadone remains the next most commonly
reported drug amongst all users (8.6%).  However, again a lower proportion of new users
reported AS use (see Figure 2.3).  AS was less commonly reported by new users (2.9%) than
amphetamine (5.1%).  These figures can be compared with Outreach services.  Heroin was
also the most commonly used drug in outreach (43.3% of new users) and methadone repre-
sented 5.9% of new users.
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Table 2.6a All Users, New Users and Visits Reported by Agency Based Syringe Exchange 
Schemes in 1999 by Main Drug
Main Drug All Users New Users Visits
Amphetamine 209 (  6.6%) 69 (  5.1%) 1,517 (  9.9%)
Anabolic Steroids 898 (28.3%) 504 (37.4%) 2,027 (13.2%)
Cocaine 73 (  2.3%) 32 (  2.4%) 343 (  2.2%)
Crack 4 (  0.1%) 2 (  0.1%) 21 (11.9%)
Heroin 1,556 (49.1%) 657 (48.7%) 8,192 (43.4%)
Methadone 273 (  8.6%) 39 (  2.9%) 1,694 (  9.0%)
Other / No Main Drug 157 (  5.0%) 46 (  3.4%) 1,595 (10.4%)
Total (100%) 3,170                                     1,349                                   15,389
Data exclude all double counting i.e. each individual is only counted once, at the last agency they attended.NB: The main drug was used was 
recorded only on the first occasion that the user was presented to services.
Table 2.5 All Users and New Users Reported by Agency Based Syringe Exchange Schemes                      
Liverpool North Cheshire Sefton
Age Group All Users         New Users All Users New Users All Users New Users
Under 15 1 (  0.1%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 2 (  0.5%) 0 (  0.0%)
15 - 19 36 (  3.6%) 30 (  7.2%) 11 (  3.3%) 9 (  4.8%) 11 (  2.6%) 9 (  5.4%)
20 - 24 153 (15.3%) 91 (22.0%) 72 (21.7%) 55 (29.1%) 73 (17.3%) 40 (23.8%)
25 - 29  320 (32.0%) 138 (33.4%) 95 (28.6%) 51 (27.0%) 144 (34.1%) 55 (32.7%)
30 -34 265 (26.5%) 91 (22.0%) 82 (24.7%) 40 (21.2%) 104 (24.6%) 41 (24.4%)
35 - 39 141 (14.1%) 39 (  9.4%) 37 (11.1%) 21 (11.1%) 53 (12.6%) 17 (10.4%)
40 - 44 44 (  4.4%) 15 (  3.6%) 21 (  6.3%) 8 (  4.2%) 19 (  4.5%) 4 (  2.4%)
45 - 49 32 (  3.2%) 8 (  1.9%) 10 (  3.0%) 5 (  2.6%) 10 (  2.4%) 2 (  1.2%)
50 and over 7 (  0.7%) 1 (  0.2%) 4 (  1.2%) 0 (  0.0%) 6 (  1.4%) 0 (  0.0%)
Total (100%)  999                 413 332 189 422 168
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority                               
both Health Authorities.41
Figure 2.2b Proportion of New Users Aged Under 25 Reported by Agency Based Syringe 
Exchange Schemes in 1996, 1997, 1998 and 1999 by Health Authority of Reporting Agency.
Figure 2.2a  Proportion of all Users Aged Under 25 Reported by Agency Based Syringe 
Exchange Schemes in 1996, 1997, 1998 and 1999 by Health Authority of Reporting Agency.
Figures 2.2a & 2.2b: Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will
only be shown at the first agency they visited whereas an individual who visits  agencies in two Health Authorities will be represented in both Health Authorities.
South Cheshire St Helens & Knowsley Wirral Total 
All Users New Users All Users New Users All Users New Users All Users New Users
  1 (  0.2%)       0 (  0.0%)  1 (  0.1%)    0 (0.0%)        0 (  0.0%)   0 (  0.0%)      5 (  0.1%)  0 (  0.0%)
  42 (  8.1%)  23 (10.9%)   35 (  4.3%)  24 (  7.3%)     4 (  0.7%)  3 (  1.9%)      39 (  3.8%)  98 (  6.7%)
118 (22.6%)   62 (29.4%) 157 (19.2%) 80 (24.2%)    49 (  9.0%)  24 (15.0%)     622 (17.1%)  352 (23.9%)
165 (31.7%)   72 (34.1%) 261 (32.0%) 111 (33.5%)  131 (24.0%)  43 (26.9%)  1,116 (30.7%)  470 (31.9%)
  99 (19.0%)      29 (13.7%)  212 (26.0.%)    64 (19.3%)  182 (33.3%)  51 (31.9%)    944 (26.0%)  316 (21.5%)
  61 (11.7%)     17 (  8.1%)  90 (11.0%)    36 (10.9%)   106 (19.4%)  25 (15.6%)    488 (13.4%)  155 (10.5%)
  27 (  5.2%)       7 (  3.3%)  41 (  5.0%)     10 (  3.0%)    42 (  7.7%)  11 (  6.9%)    194 (  5.3%)  55 (  3.7%)
  4 (  0.8%)       0 (  0.0%)  14 (  1.7%)      4 (  1.2%)    21 (  3.8%)  1 (  1.6%)       91 (  2.5%)  20 (  1.4%)
  4 (  0.8%)      1 (  0.5%)    5 (  0.6%)      2 (  0.6%)     11 (  2.0%)  2 (  1.3%)       37 (  1.0%)  6 (  0.4%)
521           211                   816               331                    546              160                 3636              1,472
in 1999 by Health Authority of Reporting Agency and Age
                    will only be shown at the first agency they visited whereas an individual who visits  agencies in different Health Authorities will be represented in
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1999Figure 2.3 shows the proportions of new users reported by agency based syringe exchange
schemes between 1996 and 1999 by their main drug of use and show that anabolic steroid use
continued to rise amongst this group.  After a significant rise in the reported number of new
users of heroin in 1997, reported heroin use fell in both 1998 and 1999 to below 1996 levels.
Likewise, methadone reports fell steadily from 1996 and in 1999 stood at a fifth of the 1996
levels.  
Table 2.6b is new and shows the visit rates per reported drug over the last four years.  The
overall visit rate (the average number of visits per individual) was 4.3 visits per individual (5.0 in
1998), but amongst users of different drugs it varied considerably.  The highest visit rate
remained amongst users of other or no main drug (10.2 per user) followed by users of
amphetamines.  The visit rates for both these groups have risen by around two thirds since
1996 whilst AS, cocaine, heroin and methadone users rates were consistent. The lower rate
amongst AS users may be the result of different drug regimes used i.e. they do not necessarily
inject every day and they have ‘off’ cycles or rest periods when they abstain from drug use.
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Figure 2.3 New Users Reported by Agency Based Syringe Exchange Schemes in 1996, 1997, 
1998  and 1999 by Main Drug
Drug 1996 1997 1998 1999
All Drugs 4.8 4.5 5.0 4.3
Amphetamine 4.6 6.2 7.2 7.3
Anabolic Steroids 2.0 2.3 2.5 2.3
Cocaine 4.2 3.6 4.2 4.7
Heroin 5.5 4.8 5.5 5.3
Methadone 6.1 5.6 6.3 6.2
Other / No Main Drug 6.2 7.9 9.0 10.2
Table 2.6b: Visit Rates for All Users by Main Drug
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Tables 2.7a and b show the breakdown of drug use by Health Authority of reporting agency.
North Cheshire and South Cheshire reported the lowest and highest proportion of all heroin
users (34.6% and 59.0%) and new heroin users (32.3% and 65.8%), respectively.  St Helens
and Knowsley Health Authority also reported more new heroin users than all users of heroin
(49.2% and 42.4% respectively).  South Cheshire and North Cheshire respectively reported
the lowest and highest proportions of AS users (14.5% and 51.9%, respectively) and new AS
users (19.9% and 56.7%).  South Cheshire also reported the highest proportion of methadone
users (16.1%) and North Cheshire and Wirral the highest proportion of new methadone users
(6.8% and 6.7%, respectively).  St Helens and Knowsley in particular reported high proportions
of amphetamine use (12.2% of all users and 11.7% of new users).  Cocaine was reported in
low proportions.  Less than 6.0% of users or new users (except amongst Sefton users where
9.4%) reported cocaine as their main drug.  See figure 2.4a, b and c for trends of heroin,
methadone and AS use for the four years from 1996  to 1999.
Table 2.7a All Users Reported by Agency Based Syringe Exchange Schemes in 1999 
by Drug and Health Authority of Reporting Agency
Health                         Amphetamine        Anabolic            Cocaine Crack Heroin             Methadone       Other/ No     Total
Authority                                                 Steroids  MainDrug  (100%)
Liverpool 22 (  2.5%) 274  (30.8%) 18  (  2.0%) 1 (  0.0%) 516  (58.0%) 27  (  3.0%) 32  (  3.6%) 890 
North Cheshire 8 (  2.8%) 150  (51.9%) 4 (  1.4%) 0 (  0.0%) 100  (34.6%) 23  (  9.0%) 4 (  1.4%) 289
Sefton 21 (  5.1%) 131  (31.7%) 22  (  5.3%) 0 (  0.0%) 170  (41.2%) 48  (11.6%) 21 (  5.1%) 413
South Cheshire 35 (  7.2%)  70 (14.5%)  2  (  0.4%)  0  (  0.0%)    285   (  59.0%)  78 (16.1%)  13 (  2.7%)  483
St Helens & Knowsley 93 (12.2%) 200  (26.3%) 9 (  1.2%) 2 (  0.3%) 322  (42.4%) 54  (  7.1%) 80 (10.5%) 760
Wirral 33 (  8.6%) 83  (21.6%) 19  (  4.9%) 1 (  0.3%) 194  (50.5%) 46  (12.0%) 8 (  2.1%) 384
Total 212 (  6.6%)      908    (28.2%   )       74 (  2.3%)     4  ( 0.1%) 1,587 (49.3%) 276 ( 8.6%) 158 (4.9%)  3,219
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be shown at the
first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be shown at both. NB: The main drug used was
recorded only on the first occasion that the user presented to services.
Table 2.7b New Users Reported by Agency Based Syringe Exchange Schemes in 1999 by Drug 
and Health Authority of Reporting Agency
Health  Amphetamine           Anabolic  Cocaine Crack             Heroin           Methadone      Other / No    Total
Authority                                                   Steroids                                Main Drug  (100%)
Liverpool 14 (  3.5%) 149  (36.8%) 6 (  1.5%) 1 (  0.2%) 214 (52.8%) 4 (  1.0%) 17 (  4.2%) 405
North Cheshire 3 (  1.7%) 102  (56.7%) 4 (  2.2%) 0 (  0.0%) 58 (32.2%) 12 (  6.7%) 1 (  0.6%) 180
Sefton 5 (  2.9%) 71 ( 41.8%) 16 (  9.4%) 0 (  0.0%) 67 (39.4%) 4 (  2.4%) 7 (  4.1%) 170
South Cheshire  10 (  5.1%) 39  (19.9%) 0 (  0.0%) 0 (  0.0%) 129 (65.8%) 9 (  4.6%) 9 (  4.6%) 196
St Helens & Knowsley 27 (  8.5%) 114  (36.0%) 2 (  0.6%) 0 (  0.0%) 156 (49.2%) 5 (  1.6%) 13 (  4.1%) 317
Wirral 12 (11.7%) 34  (33.0%) 4 (  3.9%) 1 (  1.0%) 45 (43.7%) 7 (  6.8%) 0 (  0.0%) 103
Total  71 (  5.2%)  509 (37.1%)  32 (2.3%)     2  ( 0.1%)  669 (48.8%)  41 ( 3.0%)      47 ( 3.4%)    1,371
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same  Health Authority will only be shown at
the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be shown at both. NB: The main drug
used was recorded only on the first occasion that the user presented to services.44
Figure 2.4 a) New Heroin Users Reported by Agency Based Syringe Exchange Schemes in 1996,
1997, 1998 and 1999 
Figure 2.4 b) New Methadone Users Reported by Agency Based Syringe Exchange Schemes 
in 1996, 1997, 1998 and 1999 
Figures 2.4 a, b and c show the changes in proportions of new users reporting heroin,
methadone and AS, respectively.  Reports of heroin use had generally fallen over the last four
years,  However, South Cheshire, saw a large rise in reported heroin use (from 38.9% to
65.8% of new users) but also saw a large fall in reported methadone use, from 27.2% to
7.1%.  Together, in South Cheshire these two drugs accounted for around 70% of all reported
drug use over the four years and may signify a move away from the use of prescribed drugs to
street drugs.  Thus, as Table 2.12 shows, there has been a decline in the number of SES clients
who state that they are also receiving treatment, from 30.0% in 1996 to 15.0% in 1999.
Reported AS use has always been higher in North Cheshire (at around half of all reported drug
use) than other Health Authorities.  However, while proportions remain fairly static in North
Cheshire Health Authority, Sefton and St Helens and Knowsley Health Authorities have seen
rising proportions of AS users, from 26.1% to 41.8% and from 15.7% to 36.0%, respectively.
In Wirral, the trend of falling reports of AS use between 1996 and 1998 has been reversed in
1999 when more new AS users were reported than in any previous reporting year.  Liverpool
and South Cheshire have reported consistent proportions of new AS users over the last four
years, around a third and less than a fifth, respectively.
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Table 2.8:  Most drug use is concentrated in the 25 to 34 age range; accounting for over half of
all users and for 61.0% of heroin users.  AS users represented a slightly younger age group with
60.8% being in the 20 to 29 age range and lower proportions of over 35 year olds.  Around
14% of AS users were over 35 compared with 37.6% of methadone users, 28.7% of ‘other/
no main drug’ users and 19.5% of heroin users.  Users of methadone were generally older,
with only 54.5% concentrated in the 25 to 34 age bracket but 29.1% being aged between 35
and 39 and 8.5% being over 44.  Cocaine users and those reporting ‘other / non main drug’
were also slightly older with 25.3% and 24.2%, respectively being in the 35 to 44 age bracket.
The only reported under 15 year olds were heroin users.  There was no use of crack under
the age of 25 and no cocaine use under the age of 20.
The majority (52.4%) of 15 to 19 year olds reported AS as their main drug but as users got
older the proportions reporting AS use fall to 14.7% of 45 to 49 year olds.  However 27.3% of
all those individuals over 50, reported use of AS.  In the 20 to 24 age range, AS and heroin use
were reported approximately equally (42.7% and 43.6%, respectively, of all users between 20
and 24).  However between 25 and 39 heroin is reported by just over half of users in each age
range.
Figure 2.4 c) New Anabolic Steroid Users Reported by Agency Based Syringe Exchange 
Schemes in 1996, 1997, 1998 and 1999
Table 2.8 All Users Reported by Agency Based Syringe Exchange Schemes in 1999 by Drug and Age
Age                 Amphetamine        Anabolic            Cocaine           Crack Heroin Methadone Other / No          Total
Group                                        Steroids Main Drug         (100%)
Under 15 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%) 4 (  0.3%) 0 (  0.0%) 0 (0.0%) 4 (  0.1%)
15 - 19 12 (  5.8 %) 66 (  7.4%) 0 (  0.0%) 0 (  0.0%) 46 (  3.0%) 1 (  0.4%) 1 (  0.6%) 126 (  4.0%)
20 - 24 35 (16.8%) 246 (27.5%) 10 (14.1%) 0 (  0.0%) 251 (16.2%) 21 (  7.7%) 13 (  8.3%) 576 (18.3%)
25 - 29  70 (33.7%) 298 (33.3%) 16 (22.5%) 1 (25.0%) 511 (33.0%) 63 (23.2%) 43 (27.4%) 1,002 (31.8%)
30 - 34 50 (24.0%) 161 (18.0%) 24 (33.8%) 2 (50.0%) 434 (28.0%) 85 (31.3%) 55 (35.0%) 811 (25.7%)
35 - 39 16 (  7.7%) 78 (  8.7%) 14 (19.7%) 1 (25.0%) 204 (13.2%) 50 (18.4%) 24 (15.3%) 387 (12.3%)
40 - 44 17 (  8.2%) 26 (  2.9%) 4 (  5.6%) 0 (  0.0%) 57 (  3.7%) 29 (10.7%) 14 (  8.9%) 147 (  4.7%)
45 - 49 5 (  2.4%) 10 (  1.1%) 2 (  2.8%) 0 (  0.0%) 28 (  1.8%) 16 (  5.9%) 7 (  4.5%) 68 (  2.2%)
50 and over 3 (  1.4%) 9 (  1.0%) 1 (  1.4%) 0 (  0.0%) 13 (  0.8%) 7 (  2.6%) 0 (  0.0%) 33 (  1.0%)
Total (100%) 208 894 71 4 1,548 272 157 3,154
Data exclude all double counting i.e. each individual is onlycounted once, at the first agency they attended
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1996
1997
1998
1999Table 2.9 profiles the length of time individuals had been in contact with services at their last
visit.  These data were available for 99.1% of clients in contact with SES during 1999.  New
users accounted for over half of all users; i.e. 51.1% had been in contact for one year or less.
This is higher than in the previous two years.  Data suggest an increase in short term contacts
with SES.  In 1997, 28.2% of the previous year’s new users were reported as having a contact
of one to two years (i.e. they were still in contact), in 1998 this was 26.9% and in 1999,
22.7%. Conversely more individuals remained in contact with SES for longer.  Of SES users,
17.4% were in contact for over five years compared to 15.5% in 1998, 14.7% in 1997 and
just 3.9% in 1996.  It would appear, therefore that there is an increasing polarisation of clients
with many making only brief contact (less than a year) and others remaining in long term con-
tact. 
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Table 2.10 All Users Reported by Agency Based Syringe Exchange Schemes in 1999 by Drug 
and Length of Time in Contact with Services
Time in  Amphetamines       Anabolic  Cocaine Heroin Methadone Other/No              Total
Contact                                        Steroids Main Drug
New User 95 (45.0%) 610 (67.9%) 41(52.5%) 833 (52.9%) 58 (21.3%) 58 (37.7%) 1,695 (53.1%)
1 to 2 Years 18 (  8.5%) 92 (10.2%) 6 (  7.7%) 204 (12.9%) 25 (  9.2%) 11 (  7.1%) 356 (11.2%)
2 to 3 Years 18 (  8.5%) 77 (  8.6%) 4 (  5.1%) 158 (10.0%) 43 (15.8%)  7  ( 4.5%) 307 (  9.6%)
3 to 4 Years 19 (  9.0%) 56 (  6.2%) 11 (14.1%) 116 (  7.4%) 48 (17.6%) 7  ( 4.5%) 257 ( 8.1%)
4 to 5 Years 11 (  5.2%) 22 (  2.4%) 4 (  5.1%) 81 (  5.1%) 16 (  5.9%) 8  ( 5.2%) 142 (  4.5%)
5 to 6 Years 6 (  2.8%) 12 (  1.3%) 5 (  6.4%) 57 ( 3.6%) 9  ( 3.3%) 16 (10.4%) 105 (  3.3%)
6 to 7 Years 7 (  3.3%) 14 (  1.6%) 6 (  7.7%) 56 (  3.6%) 11 (  4.0%) 13 (  8.4%) 107 (  3.4%)
7 to 8 Years 29 (13.7%) 14 (  1.6%) 1 (  1.3%) 55 (  3.5%) 46 (16.9%) 28 (18.2%) 173 (  5.4%)
8 to 9 Years 8 (  3.8%) 2 (  0.2%) 0 (  0.0%) 16 (  1.0%) 16 (  5.9%) 6 ( 3.9%) 48 ( 1.5%)
Total (100%) 211 899 78 1,576 272 154                3,190
Data exclude all double counting i.e. each individual is only counted once, at the first agency they attended.  
Drug is only collected on first contact with services and may change over time without being reflected in later reports
Table 2.9 All Users Reported by Agency Based Syringe Exchange Schemes in 1996, 1997, 1998 
and 1999 by Length of Time in Contact with Services
Time in Contact                         1996                               1997 1998                             1999
New User  2,313 (61.0%)  1,792 (48.7%)  1,751 (50.5%)  1,870 (51.1%)
to 2 Years 380 (10.0%) 653 (17.8%) 482 (13.9%) 398 (10.9%)
2 to 3 Years 256 (  6.8%) 332 (  9.0%) 391 (11.3%) 326 (  8.9%)
3 to 4 Years 207 (  5.5%) 179 (  4.9%) 169 (  4.9%) 266 (  7.3%)
4 to 5 Years 489 (12.9%) 176 (  4.8%) 137 (  4.0%) 159 (  4.3%)
5 to 6 Years }*                     225 (  6.1%)   143 (  4.1%)  126 (  3.4%)
6 to 7 Years                    }     147 (  3.9%) 313 (  8.5%)  303 (  8.7%)  142 (  3.9%)
7 to 8 Years } 5 (  0.1%)   92 (  2.7%)  290 (  7.9%)
to 9 Years } 1 (  0.0%)  0 81 (  2.2%)
Total (100)% 3,792                         3,676 3,468 3,658
Data for 1996 and 1997 are for all users including double counting of users who presented at more than one agency. Data for 1998 and 1999 exclude double
counting across Health Authorities. * Owing to low numbers in 1996,  contacts over five years were analysed togetherFurther research is necessary to try to establish the career of those who leave services and
establish if they appear at other exchange services, in treatment, the criminal justice system or
if they disappear from monitoring because they cease injecting and/or drug taking.
Table 2.10 shows the main drug of use by the length of contact with SES.  As in 1998, anabolic
steroid users were those with the shortest length of contact with services.  In 1999 a smaller
proportion of AS users (86.7%) had been in contact for between one and three years than in
1998 (90.5%).  This  suggests that many of the increasing number of individuals who have
made contact for their AS use over the last three years (see Tables 2.7a and 2.7b and Figure
2.4c) are not staying in contact with services.   
Contacts of between seven and eight years accounted for 13.7% of amphetamine users,
16.9% of methadone users and 18.2% of users of the other / poly drug users category.  This
figure coincides with the beginning of SES monitoring in 1991, when individuals were first
reported. 
Table 2.11: As in previous years the most commonly reported method of hearing about ser-
vices was from family and friends (78.2% of all users and 79.4% of new users), see Table
2.11.  This method was followed by ‘Other’ (8.0%) and Outreach (5.0%) amongst all users
and by Outreach (6.4%) and ‘Other’ (5.9%) amongst new users.  All and new female users
were more likely to have heard about SES services from a clinic (6.2% and 8.1%, respectively)
than males (3.4% and 3.2%, respectively) and this may be the result of sex workers attending
clinics.  
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Table 2.11 All Users and New Users Reported by Agency Based Syringe Exchange Schemes in
1999 by Sex and How Clients Heard About Services
All Users New Users Total
How Heard Female Male Female Male All Users New Users
Chemist 2 (  0.5%) 14 (  0.5%) 1 (  0.7%) 6 (  0.5%) 16 (  0.5%) 7 (  0.6%)
Clinic 26 (  6.2%) 87 (  3.4%) 12 (  8.1%) 33 (  3.2%) 113 (  3.8%) 45 (  3.8%)
Friend / Family 323 (77.5%) 2,003 (78.3%) 116 (77.9%) 789 (77.1%) 2,326 (78.2%) 905 (77.2%)
GP 2 (  0.5%) 21 (  0.8%) 1 (  0.7%) 4 (  0.4%) 23 (  0.8%) 5 (  0.5%)
Healthwise 1 (  0.2%) 2 (  0.1%) 0 (  0.0%) 2 (  0.2%) 3 (  0.1%) 2 (  0.2%)
Leaflet 3 (  0.7%) 37 (  1.4%) 0 (  0.0%) 13 (  1.3%) 40 (  1.3%) 13 (  1.1%)
Outreach 24 (  5.8%) 124 (  4.8%) 7 (  4.7%) 60 (  5.9%) 148 (  5.0%) 67 (  5.7%)
Police 0 (  0.0%) 1 (  0.0%) 0 (  0.0%) 1 (  0.1%) 1 (  0.0%) 1 (  0.1%)
Poster 1 (  0.2%) 18 (  0.7%) 0 (  0.0%) 3 (  0.3%) 19 ( 0.6%) 3 (  0.3%)
Press 1 (  0.2%) 13 (  0.5%) 0 (  0.0%) 5 (  0.5%) 14 (  0.5%) 5 (  0.4%)
Prison 4 (  1.0%) 24 (  0.9%) 2 (  1.3%) 17 (  1.7%) 28 (  0.9%) 19 (  1.6%)
TV / Radio  2 (  0.5%) 3 (  0.1%) 0 (  0.0%) 1 (  0.1%) 5 (  0.2%) 1 (  0.1%)
Other 28 (  6.8%) 211 (  8.2%) 10 (  6.7%) 90 (  8.8%) 239 (  8.0%) 100 (  8.5%)
Total (100%)  417  2,558  149             1,024               2,975                 1,173
Data  exclude all double counting i.e. each individual is only counted once, at the first agency they attended48
Table 2.12 All Users, New Users and Visits Reported by Agency Based Syringe Exchange Schemes
in 1999 by Whether Clients Were Receiving Treatment for Their Drug Use
In Treatment? All Users New Users Visits
Yes 801 (26.8%) 174 (15.0%) 5,206 (34.8%)
No 2,190 (73.2%) 985 (85.0%) 9,767 (65.2%)
Total (100%) 2,991 1,159  14,973
Data exclude all double counting i.e. each individual is only counted once, at the first agency they attended
Table 2.12:  In 1999 the decline in the proportions of SES clients who were also receiving treat-
ment for their drug dependency continued.  Amongst new users this has dropped from nearly a
third (30.0%) in 1996 to less than a fifth (15.0%) in 1999.  The continuing increase in AS users
may, in part, account for this.  AS users may see their drug use as recreational or sports related
and therefore not problematic and needing treatment.  Of 39 new methadone users, 53.0%
were in receipt of treatment (which could include their methadone use), and the remaining
46.2% were either not in treatment (17.9%) or their treatment status was unknown (28.2%).
The visit rates for those receiving and not receiving treatment, at 6.5 and 4.7, respectively, were
very similar to previous years.  They indicate that those who receive treatment are more likely
to make more visits, possibly because they are more aware of harm minimisation methods ortheir habit is greater.
Table 2.13:  Clients were asked if they had shared any injecting equipment in the four weeks
prior to visiting SES, or since their last visit if that was less than four weeks ago.  Overall 4.0%
of individuals had shared some part of injecting ‘gear’.  However, there was variation across
users of different drugs, with other / poly drug users, heroin and cocaine recording the highest
levels of sharing (6.6%, 5.7% and 4.0% respectively).  Users of all other drugs reported sharing
in less than 2% of cases.  Data for previous years included double counting of individuals who
had visited an SES several times, or had visited several different SES agencies and therefore are
not comparable.  Although these figures are low in line with KPI 3.3 (see Box 1) and KPT 3
(see Box 2), the low response rates should be borne in mind.  Also the stigma attached to
admitting sharing, especially at a place dedicated to the provision of sterile injecting equipment
may influence response rates.  Further research needs to be undertaken if true rates of sharing
are to be established.  By comparison, a fifth (21%) of individuals reported both to the DMD in
1998
4 and to the Unlinked Anonymous study in 1995 reported having shared injecting equip-
ment in the last four weeks
26.
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Table 2.13 All Users Reported by Syringe Exchange Schemes in 1999 by Sharing Status and Drug
Have you shared injecting equipment in the last four weeks?
Drug                                             Yes      No Total (100%)
Amphetamine 2 (  1.6%) 123 (98.4%) 125
Anabolic Steroids 7 (  1.5%) 474 (98.5%) 481
Cocaine 2 (  4.6%) 41 (95.3%) 43
Heroin 52 (  5.7%) 864 (94.3%) 916
Methadone 1 (  1.0%) 104 (99.0%) 105
Other / No Main Drug 8 (  6.6%) 113 (93.4%) 121
Total 272 ( 4.0%) 1,719 (96.0%) 1,790
Data exclude all double counting i.e. each individual is only counted once, at the first agency they attended50
t h r e e
PHARMACY BASED SYRINGE 
EXCHANGE SCHEMES
SECTION 351
DEFINITIONS
User A person who visits a pharmacy for the purposes of needle and/or 
Syringe Exchange - they may be a new user or a repeat user.
New User A user visiting a pharmacy for the first time.
Repeat User A user visiting a pharmacy for the second or any subsequent time regardless 
of length of time between visits.
Visit When a person visits a pharmacy for the purposes of needle exchange for 
the first or any subsequent time.  
NB this is not the same as an episode reported to the Drug Misuse Database.
Visit Rate The number of visits divided by the number of users to give an average 
number of visits made by  each user.
Double Counting If a person visits more than one pharmacy in Merseyside and Cheshire or 
with in a Health Authority and is counted as a user at each pharmacy or 
Health Authority that they visit.
Single Counting If a person visits more than one pharmacy in Merseyside and Cheshire or 
within a Health Authority and they are counted in only one (the first they
visited).
Introduction
In 1999, a total of 59 pharmacies in the six Health Authorities of Merseyside and Cheshire
reported attributable data (initials, date of birth and sex) to the Drug Monitoring Unit, with
pharmacies within the Liverpool Health Authority area changing from summary to attributable
reporting in January of 1999.
This data set is the smallest set of variables collected by the Drug Monitoring Unit.  This is due
to the anonymous nature of the pharmacy based exchange schemes (Pharmacy), i.e. the fact
that transactions take place in a shop regularly used by non drug user members of the local
community.  The data items collected are: initials, date of birth, sex, area of residence (on firstvisit) and details of syringes exchanged.  The drug(s) of use are not recorded.
To understand the service needs of drug users, comprehensive monitoring of all services is
required and data gathered from Pharmacies offering needle and syringe exchange services can
assist in the local monitoring of the objectives of the Government drugs strategy (see Box 1).
Continued monitoring of these services will show trends in ages of drug misusers and, added to
data collected from other services in Merseyside and Cheshire, may aid the assessment of the
numbers in contact with services for drug misusers (KO3, Objective 3), and also the propor-
tions of drug users who are injecting (Objective 3.2)
In 1999, 5,259 individuals were reported by all Pharmacies in the Merseyside and Cheshire
area, of whom 277 (5.3%) visited Pharmacies in more than one Health Authority.  In 1998 only
88 individuals (2.6%) visited Pharmacies in more than one Health Authority.  However in 1999
Pharmacies in Liverpool Health Authority reported attributable data for the first time which may
account for the increase, as city centre Pharmacies may attract ‘passing trade’.  New users
accounted for two thirds of all users (67.2% or 3,721 individuals), similar to 1998 when 64%
of all users were new to services.  Of new users, 159 (4.3%) had visited Pharmacies in more
than one area.  When double counting across Health Authorities is included (i.e. when an indi-
vidual is counted in all Health Authorities in which they visit a Pharmacy) the number of users
recorded was 5,536 and the number of new users was 3,880 (see Table 3.1).  This represents
a considerable fall in numbers of users reported in previous years.  However this is primarily
accounted for by the changed activity levels reported by those Pharmacies in Liverpool Health
Authority.  Here the number of users fell from 11,421 to 1,538 although the number of new
users remained about the same.  When only those Pharmacies that reported attributable data in
1998 are included compared between 1998 and 1999, attendance figures are similar with
3,466 users and 2,231 new users being reported in 1998 compared to 3,955 and 2,342,
respectively in 1999.  Fewer Pharmacies from Liverpool Health Authority reported in 1999 (12,
compared to 17 in 1998).
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Table 3.1 All Users, New Users and Visits Reported by Pharmacy Based Syringe Exchange 
All Users          New Visits All New Visits
Health Authority Users Users            Users Users
Liverpool 5,297 909 17,395 10,449 2,669 30,03
North Cheshire 342 316 2,213 452 317 1,203
Sefton 2,790 123 9,669 2,856 149 10,286
South Cheshire 832 825 5,356 1,168 704 3,389
St Helens & Knowsley 1,949 326 6,519 2,153 413 5,517
Wirral 566 346 2,66 735 467 2,046
Total (100%) 11,776 2,845 43,814 17,813 4,719 52,472
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be shown                            
1996 1997Table 3.2 shows the sex and age profile of all users and new users attending Pharmacies in
1999.  Altogether, 3,775 males were reported by Pharmacies in 1999, that is 71.8% of all
reported individuals for whom sex was recorded.  This gives a female to male ratio of 1:3.8.  A
fifth of all users and  new users were female (20.2% and 20.5%, respectively).  This compares
to 14.3% of all users and 13.0% of new users reported to the Drug Monitoring Unit by SES,
31.3% at SDS and two thirds reported by Outreach services (65.5% of all and new users).  
The most common age group for both male and female users and new users was 25 to 29
years, representing an ageing population of  female Pharmacy clients.  In 1998 females were
more likely to be aged between 20 and 24.  Females presenting at Pharmacy syringe exchanges
in 1999 were generally younger than males, with 31.5% of all users and 29.1% of female new
users being aged under 25 compared to 22.1% and 20.8% of males. This represents a similar
age distribution to clients of SES, with SDS visitors being slightly older, mainly aged 30 to 34.
Compared with 1999, in 1998 considerably higher proportions of both male and female
Pharmacy clients were aged under 25 (27.3% of male and 40.4% of female users and 26.7%
and 40.2% of new users, respectively). 
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Table 3.2 All Users and New Users Reported by Pharmacy Based Syringe Exchange Schemes in 
1999 by Sex and Age
Age Group Male Female Male Female
Under 15 6 (  0.2%) 0 (  0.0%) 6 (  0.2%) 0 (  0.0%)
15 - 19  129 (  3.8%) 64 (  7.4%) 81 (  3.2%)  39 (  5.9%)
20 - 24  620 (18.1%)  209 (24.1%)  445 (17.4%)  153 (23.2%)
25 - 29  1,105 (32.2%) 263 (30.3%) 827 (32.3%) 211 (32.0%)
30 -34 973 (28.4%) 211 (24.3%) 737 (28.8%) 162 (24.6% )
35 - 39 389 (11.3%) 89 (10.3%) 306 (12.0%) 73 (11.1%)
40 - 44 146 (  4.3%) 18 (  2.1%) 112 (  4.4%) 12 (  1.8%)
45 - 49 40 (  1.2%) 9 (  1.0%) 27 (  1.1%) 7 (  1.1%)
50 and over 21 (  0.6%) 5 (  0.6%) 17 (  0.7%) 2 (  0.3%)
Total (100%)       3,429 868 2,558 659
Data exclude all double counting i.e. each individual is only counted once, at the first agency they attended.  
All Users New Users
Schemes in 1996, 1997, 1998 and 1999 by Health Authority of Reporting Agency
All New Visits                            All New Visits
Users                   Users Users                   Users
11,421 1,541 31,426 1,581 1,538 23,706
580 410 2,011 573 364 4,683
425  234  2,450  500  214  7,604
1,234 794 4,007 1,485 838 11,134
506 282 1,518 632 423 4,646
721 511 2,314 765 503 6,015
14,887 3,772 43,726 5,536 3,880 57,788
                     at the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be represented in both Health Authorities.
1998 199954
Table 3.3 All Users and New Users Reported by Pharmacy Based Syringe Exchange Schemes                          
1998
All Users                                                            All Users
Health Authority Female Male Female Male
Liverpool N/K N/K N/K N/K
North Cheshire 88  (15.3%) 487  (84.7%) 58  (14.2%) 351  (85.8%)
Sefton 69  (21.6%) 251  (78.4%) 35  (22.2%) 123  (77.8%)
South Cheshire 223  (21.3%) 823  (78.7%) 163  (23.8%) 522  (76.2%)
St Helens & Knowsley 59  (15.3%) 327  (84.7%) 41  (18.5%) 181  (81.5%)
Wirral 120 (17.0%) 586  (83.0%) 86  (17.1%) 418  (82.9%)
Total 559 (18.4%)  2,474 (81.6%)  383 (19.4%)  1,595 (80.6%)
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be shown                             
both Health Authorities
Table 3.3 shows the sex profile of all users and new users by Health Authority of reporting
Pharmacy and includes double counting of those individuals who visited agencies in more than
one Health Authority.  Sex was recorded for 89.8% of all users and 91.8% of new users.  For
females the proportion of all and new users reported by Pharmacies has risen slightly over the
last four years from 17.2% of all users and 16.9% of new users in 1996 to 20.3% of all users
and 20.7% of new users in 1999.  The female to male ratio is now 1:3.9 for all users and 1:
3.8 for new users.   The proportions of females reported varied across the Health Authorities.
As in 1998, St Helens and Knowsley Pharmacies reported the lowest proportion of females
(14.7% in 1999, 15.3% in 1998) and Sefton Pharmacies the highest (24.7% in 1998 and
21.6% in 1998).  Sex data were not available for these Health Authorities prior to 1998.
North Cheshire reported a greater proportion of females in 1999 than in 1998 (17.1% and
15.3% respectively), representing a return to 1996 and 1997 levels.  South Cheshire has
reported rising proportions of females from 15.2% in 1996 to 22.5% in 1999 and from 15.0%
of new users to 22.7% in 1999.  Conversely Wirral Health Authority Pharmacies reported
lower proportions of females in 1999 than in 1996 (17.1% of all users compared to 20.4% in
1996 and 18.9% of new users compared to 20.2% in 1996).  
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only  be shown at                          
* Age is only available for new users in Liverpool Health Authority
Table 3.4 All Users and New Users Reported by Pharmacy Based Syringe Exchange Schemes 
Under 15 4 ( 0.3%) 0 (  0.0%) 0 (  0.0%) 1 (  0.4%) 1 (  0.8%) 0 (  0.0%) 0 (  0.0%)
15 - 19  25 ( 1.9%) 24 (  4.4%) 17 (  4.8%) 4 (  1.5%) 4 (  3.2%) 127 (  8.8%) 59 (  7.1%)
20 - 24 187 (14.2%) 113 (20.8%) 76 (21.5%) 32 (12.1%) 18 (14.4%) 404 (28.1%) 239 (28.9%)
25 - 29  418 (31.8%) 194 (35.7%) 128 (36.2%) 95 (35.8%) 41 (32.8%) 426 (29.6%) 254 (30.8%)
30 -34 423 (32.2%) 131 (24.1% ) 80 (22.6% ) 86 (32.5% ) 40 (32.0% ) 311 (21.6% ) 176 (21.3% )
35 - 39 168 (12.8%) 40 (  7.4%) 30 (  8.5%) 30 (11.3%) 14 (11.2%)  117 ( 8.1%) 63 (  7.6%)
40 - 44 60 ( 4.6%) 26 (  4.8%) 15 (  4.2%) 9 (  3.4%) 3 (  2.4%) 42   ( 2.9%) 28 (  3.4%)
45 - 49 23 ( 1.7%) 10 (  1.8%) 4 (  1.1%) 3 (  1.1%) 2 (  1.6%) 5   (  0.3%) 2 (  0.2%)
50 and over 7 ( 0.5%) 6 (  1.1%) 4 (  1.1%) 5 (  1.9%) 2 (  1.6%) 5   (  0.3%) 5 (  0.6%)
Total (100%)   1,315                   544  354 265 125 1,437 826
Liverpool  North Cheshire                      Sefton South Cheshire
Age Group              All Users             All Users       New Users         All Users      New Users            All Users        New Users55
                 1998 and 1999 by Sex and Health Authority of Reporting Agency
1999
All Users                                                                     New Users
Female                                      Male Female                                Male 
317  (21.7%)  1,141  (78.3%) 308  (21.8%) 1,107  (78.2%)
97  (17.1%) 470  (82.9%) 68  (18.8%) 293  (81.2%)
100  (24.7%) 305  (75.3%) 50  (25.4%) 147  (74.6%)
295 (22.5%) 1,016  (77.5%) 175  (22.7%) 597  (77.3%)
71  (14.7%) 413  (85.3%) 45  (13.6%) 285  (86.4%)
127  (17.1%) 617 (82.9%) 92  (18.9%) 396  (81.1%)
1,007  (20.3%) 3,962 (79.7%) 738  (20.7%) 2,825  (79.3%)
                      at the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be represented in 
Table 3.4 shows the ages of all users and new users by Health Authority.  Date of birth was recorded
for 4,661 (84.2%) users and 3,394 (87.5%) new users.  Overall, a majority of all users (59.3%) and
new users (60.2%) were in the 25 to 34 age bracket with 25 to 29 being the most commonly reported
age group (32.0% of all users and 32.4% of new users).  South Cheshire clients were a little younger
having a greater proportion of clients than other Health Authorities being aged between 20 and 24
(28.1% of all users and 28.9% of new users).  South Cheshire reported the largest proportion of
under-25s (36.9% of all users and 36.0% of new users).  Wirral Health Authority reported only 10.9%
of users and 9.4% of new users in the 20 to 24 age group and only 12.5% of users and 10.7% of new
user aged under 25.
                 the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be represented in both Health Authorities.
in 1999 by Health Authority of Reporting Agency and Age
St Helens & Knowsley                                         Wirral                                                     Total
All Users           New Users All Users           New Users                           All Users          New Users
1 (  0.3%) 1 (  0.3%) 0 (  0.0%) 0 (  0.0%) 6 (  0.1%) 6 (  0.2%)
20 (  5.1%) 15 (  5.1%) 11 (  1.6%) 6 (  1.3%) 211 (  0.1%) 126 (  3.7%)
286 (21.9%) 65 (22.0%) 77 (10.9%) 45 (  9.4%) 899 (19.3%) 630 (18.6%)
127 (32.3%) 95 (32.1%) 230 (32.5%) 162 (33.9%) 1,490 (32.0%) 1,098 (32.4%)
92 (23.4% ) 69 (23.3%) 231 (32.7% ) 156 (32.6%) 1,274 (27.3%) 944 (27.8%)
49 (12.5%) 38 (12.8%) 126 (17.8%) 93 (19.5%) 530 (11.4%) 406 (12.0%)
14 (  3.6%) 11 (  3.7%) 20 (  2.8%) 11 (  2.3%) 171 (  3.7%) 128 (  3.8%)
2 (  0.5%) 1 (  0.3%) 9 (  1.3%) 4 (  0.8%) 52 (  1.1%) 36 (  1.1%)
2 (  0.5%) 1 (  0.3%) 3 (  0.4%) 1 (  0.2%) 28 (  0.6%) 20 (  0.6%)
393            296 707 478 4,661 3,394LIVERPOOL
Aigburth 44 44 981
City 1,851 1,796 15,693
Dingle 15 15 454
Edge Hill 35 35 129
Fazakerley 96 96 1,444
Garston 27 27 246
Norris Green 126 126 766
Old Swan 181 180 850
Speke 16 16 530
Toxteth [1] 153 153 619
Tuebrook 254 253 1,900
West Derby [1] 13 13 94
NORTH CHESHIRE
Fearnhead 132 90 416
Runcorn New Town 115 56 935
Runcorn Old Town 75 51 476
Warrington [1] 47 28 497
Warrington [2] 124 56 1,088
Warrington [3] 139 113 760
Widnes 87 60 481
SEFTON
Ainsdale 8 0 220
Birkdale 21 7 191
Bootle 102 13 2,491
Churchtown 14 6 129
Netherton 86 32 314
Seaforth 175 108 764
Southport 289 192 3,495
SOUTH CHESHIRE
Barnton 16 7 82
Blacon 89 50 525
Chester 301 174 2,932
Congleton [1]  41 23 322
Crewe [1] 234 161 1,485
Crewe [2] 65 15 319
Knutsford 26 12 137
Macclesfield [1] 134 84 484
Macclesfield [2] 361 172 1,832
Macclesfield [3] 76 39 382
Middlewich 23 8 155
Northwich [1] 37 21 288
Northwich [2] 77 43 528
Sandbach 41 22 333
Wilmslow 57 39 500
Winsford 96 54 664
ST HELENS & KNOWSLEY
Halewood 23 16 122
Haydock 28 28 419
Kirkby 23 21 64
Newton-le-Willows    40 19 226
St Helens 444 303 2,438
West Vale 163 98 1,377 
WIRRAL
Birkenhead [1] 280 204 1,694
Birkenhead [2] 171 107 1,304
Eastham 15 6 287
Great Sutton 54 24 283
Leasowe 2 1 38
Moreton 66 30 490
Rock Ferry 97 75 510
Wallasey [1] 53 28 368
West Kirby [2] 23 9 445
Whitby 16 6 52
Woodchurch 93 72 499
Table 3.5 All Users, New Users and Visits Reported by Pharmacy Based Syringe Exchange     
Schemes in 1999 by Reporting Pharmacy
Data include double counting i.e. individuals are counted at all agencies they attended during 1998
Table 3.5 shows the number of users, new users and visits reported by each of the Pharmacies
offering syringe exchange services in Merseyside and Cheshire in 1999.  Pharmacy locations,
rather than their names are given for confidentiality reasons and where a number appears in
brackets after a Pharmacy location there is more than one pharmacy offering syringe exchange
services in that town or area.  “0” indicates that there were zero records.  Those Pharmacies in
Liverpool only began recording attributable data in 1999 and therefore, with a few exceptions,
the date of first attendance is shown as being in 1999 even though they may have visited in
previous years.
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Table 3.6 All Users Reported by Pharmacy Based Syringe Exchange Schemes in 1999 by Health
Authority of Reporting Agency and Health Authority of Residence
Health Authority of Reporting Agency
Health Authority  Liverpool North Sefton South St Helens
of Residence Cheshire Cheshire & Knowsley Wirral T otal
Liverpool 1,221 2 4 0 3 5 1,235
North Cheshire 5 563 0 1 15 1 585
Sefton 58 0 151 0 0 0 209
South Cheshire 1 0 0 1,452 0 66 1,519
St Helens & Knowsley 25 0 1 0 190 0 216
Wirral 16 0 0 0 0 678 694
Total 1,326 565 156 1,453 208 750 4,458
Double counting is excluded within Health Authorities. e.g. an individual who visits two different agencies within the same Health Authority will only be
shown at the first agency they visited whereas an individual who visits two different agencies in two different Health Authorities will be represented in 
both Health Authorities.
Table 3.6 shows the number of users reported by Pharmacy based syringe exchanges by Health
Authority of residence and the Health Authority of the reporting agency.  For example five indi-
viduals reported by an agency or agencies in Liverpool, were resident in South Cheshire.
Pharmacies mostly saw individuals who lived within the same Health Authority and a few individ-
uals from neighbouring Health Authorities.  Altogether, 9.6% of Wirral clients, 8.6% of St
Helens and Knowsley and 7.9% of Liverpool clients were resident in other Health Authorities,.
No individuals resident outside Merseyside and Cheshire were reported.  In 1998 there were
four clients from neighbouring postcode districts not within Merseyside and Cheshire but within
the North West Region.58
f o u r
SECTION 4
OUTREACH SERVICESIntroduction
The Merseyside and Cheshire area is unique in collecting data from outreach services
(Outreach) and these data can assist in the local monitoring of the objectives of the
Government’s drugs strategy.  These include tracking trends in contacts with vulnerable groups
(Objective 1.5), the proportion of drug misusers in contact with services (KO3, objective 3.1)
and the proportions of drug users who are injecting (Objective 3.2).
In 1999, nine agencies reported outreach data.  Of those agencies that reported in 1998, both
North Cheshire services (Halton CDT and Lifeline) ceased outreach work.  Also The Lodge
(Wirral) ceased outreach work.  Outreach services in North Liverpool are now carried out by
workers from the Maryland Centre in Liverpool, and reported as Maryland data.  Kirkby CDT
began reporting outreach data at the beginning of 1999.  The following data are recorded for
every individual who contacts an Outreach worker for the first time: sex, client type, main drug,
whether the drug is prescribed, whether the person is also attending SES and how the worker
and client met.  Additionally, on every contact date, geographical area and setting of contact,
referrals to other agencies made by the Outreach worker, the client’s recent drug related con-
tacts, the duration of the meeting and details of any syringe issues or returns or any condom
issues are also collected.  Possible client types are:- injecting drug users; non-injecting drug user;
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DEFINITIONS
User A person who contacts, or is contacted by, an Outreach worker.
New User A person visiting services for the first time.
Contact When a user is in contact with an Outreach worker, for the first or 
any subsequent time.
NB this is not the same as episode reported to the  Drug Misuse Database
Contact Rate The number of contacts divided by the number of users to give an 
average number of contacts  made by each user.Table 4.1 All Users, New Users and Contacts Reported by Outreach Services in 1997, 1998 and                 
1997
Health Authority All Users New Users Contact
Liverpool 688 (16.8%) 587 (16.7%) 3,160 (15.5%)
North Cheshire 494 (12.1%) 343 (  9.8%) 2,199 (10.8%)
Sefton 501 (12.2%) 370 (10.5%) 3,984 (19.5%)
South Cheshire 949 (23.2%) 818 (23.3%) 3,073 (15.0%)
St Helens & Knowsley 274 (  6.7%) 209 (  6.0%) 1,008 (  4.9%)
Wirral 1,192 (29.1%) 1,181 (33.7%) 7,013 (34.3%) 
Total (100%)                             4,098 3,508                         20, 437
injecting prostitute; non-injecting prostitute; sexual partner of client; sexually active person (who
does not fall into any other category) and other (usually ‘not known’).  Attributor codes (initials,
date of birth and sex) are not available for clients of outreach services and therefore individuals
reported by outreach cannot be included in the analyses of multi-agency contact presented in
Section Five.  Recording of outreach service data are under continuous review, and although the
collection of clients’ initials and date of birth is seen by many who work with these individuals as
being controversial, there is a need to assess the impact of outreach work both on individuals
seen and their drug taking and risk behaviours and on associated services.  A pilot project to col-
lect attributor data from clients of one outreach service (based at the Maryland Centre) began
early in 2000 and so in future it may be possible to analyse such crossover between services.
Table 4.1 shows the number and proportion of users, new users and contacts reported by out-
reach services in each Health Authority.  In 1999 only nine agencies contributed outreach data
compared to twelve in previous years.  Halton CDT, Lifeline and The Lodge all ceased outreach
work during 1999 and therefore no data were reported from them.  Kirkby CDT began report-
ing outreach data at the beginning of the year.  Altogether 3,316 individuals were reported by
the twelve participating agencies, of whom 1,470 (44.3% of users) were new to services.  This
represents 9% fewer users and 12% fewer new users than in 1998.  However these individuals
made more contacts than in the previous year. St Helens and Knowsley reported 79.2% of
their clients as being new to services.  The overall contact rate (the average number of contacts
per person in 1999) was 4.6 compared to 4.1 contacts per user in 1998 and 5.0 in 1997.
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Data for Wirral in 1998 were estimated, based on six month figures from Response. Data are for all users and visits, including multiple counts of                                                      1999 by Health Authority of Reporting Agency 
1998  1999
All Users New Users     Contacts All Users New Users Contacts
509 (17.1%) 287 (20.2%) 2,305  (18.6%) 286 (  8.6%) 106 (  7.2%) 1,404 (  9.2%)
105 (  3.5%) 33 (  2.3%) 185  (  1.5%) 0 (  0.0%) 0 (  0.0%) 0 (  0.0%)
537 (18.0%) 194 (13.6%) 3,723  (30.1%) 389 (11.7%) 111 (  7.6%) 2,914 (19.0%)
939 (31.5%) 572 (40.2%) 2,863  (23.1%) 954 (28.8%) 537 (36.5%) 2,568 (16.8%)
181 (  6.1%) 67 (  4.7%) 632  (  5.1%) 428 (12.9%) 339 (23.1%) 2,006 (13.1%)
1,407•(1,407* 532*  (  532* 5,275* (  5,275* 1,259 (38.0%) 377 (25.6%) 6,431 (42.0%)
3,678 1,685 14,983 3,316  1,470 15,323
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Table 4.2 All Users and Contacts Reported by Outreach Services in 1999 by Reporting Agency
Agency All Users New Users Contacts
Chester CDT 354 (10.7%) 51 (  3.5%) 1,636 (10.7%)
Kirkby CDT 89 (  2.7%) 89 (  6.1%) 448 (  2.9%)
The Maryland Centre 286 (  8.6%) 106 (  7.2%) 1,404 (  9.2%)
Response (Wirral) 1,259 (38.0%) 377 (25.6%) 6,431 (42.0%)
South Cheshire CDT 600 (18.1%) 486 (33.1%) 932 ( 6.1%)
South Knowsley CDT 239 (  7.2%) 206 (14.0%) 1,294 (  8.4%)
South Sefton MDC 95 (  2.9%) 49 (  3.3%) 319 (  2.1%)
Southport MDC 294 (  8.9%) 62 (  4.2%) 2,595 (16.9%)
St Helens CDT 100 (  3.0%) 44 (  3.0%) 264 (  1.7%)
Total (100%) 3,316 1,470 15,323
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.
Table 4.2 shows the agency profile for all users, new users and contacts in 1999.  Kirkby CDT
reported outreach data for the first time in 1999, whilst Halton CDT, Lifeline, North Liverpool
CDT and the Lodge all ceased providing Outreach services.  Most Outreach services that
reported in both 1998 and 1999 reported approximately the same number of individuals in
each year.  However, the Maryland Centre reported around a quarter fewer users and only
half the number of new users in 1999.  In 1998 South Knowsley CDT had a reduced outreach
team and so reported very few individuals, however in 1999 the figures returned to 1997 lev-
els of around 200 users.
As in previous years South Cheshire CDT succeeded in contacting a large population of drug
users new to their service, with 81% of their clients being new in 1999.  Kirkby CDT began
recording data in 1999 and so all their clients will have their first recorded contact in 1999 even
though they may have been in contact earlier.  The contact rate varied from 1.5 contacts per
user at South Cheshire CDT to 8.8 at Southport MDC which is a similar range to that in 1998.
                     individuals who presented at more than one agency.62
Table 4.4 All Users and New Users Reported by Outreach Services in 1999 by Drug and Health                      
Drug
Health                                              Amphetamine Anabolic   Cocaine Crack           Heroin
Authority Steroids
Liverpool All Users 1 (  0.9%) 0 (  0.0%) 1 ( 0.9%) 1 (  0.9%) 110 (94.8%)
New Users 0 (  0.0%) 0 (  0.0%) 1 ( 1.6%) 1 (  1.6%) 58 (93.5%)
Sefton All Users 25 (13.7%) 0 (  0.0%) 14 (  7.7%) 1 (  0.5%) 116 (63.7%)
New Users 14 (16.7%) 0 (  0.0%) 8 (  9.5%) 0 (  0.0%) 51 (60.7%)
South Cheshire All Users 56 (13.0%) 18 (  4.2%) 6 (  1.4%) 18 (  4.2%) 148 (34.3%)
New Users 11 (  8.3%) 7 (  5.3%) 0 (  0.0%) 10 (  7.5%) 33 (24.8%)
St Helens & Knowsley  All Users 19 (  6.4%) 4 (  1.3%) 9 (  3.0%) 4 (  1.3%) 139 (46.8%)
New Users 17 (  7.1%) 3 (  1.3%) 9 (  3.8%) 4 (  1.7%) 106 (44.2%)
Wirral All Users 31 (  5.1%) 0 (  0.0%) 24  (  3.9%) 3 (  0.5%) 366 (59.7%)
New Users 21   9.3(%) 0 (  0.0%) 9 (  4.0%) 3 (  1.3%) 74 (32.9%)
Total: All Users 132 (8.0%) 22 (  1.3%) 54 (  3.3%) 27 (  1.6%) 879 (53.6%)
New Users 63 (8.5%) 10 (  1.3%) 27 (  4.6%) 18 (  2.4%) 322 (43.3%)
Table 4.3:  Clients’ sex was recorded for 85.9% of individuals, an improvement on 76.8% in
1998 and 81.6% in 1997.  Outreach services saw the highest proportions of females in all 
services reporting to the Drug Monitoring Unit.  Furthermore, in 1999 the highest proportion
of females for four years was reported.  Two thirds of Outreach clients were female (65.6% of
all users and 65.0% of new users;  see Table 4.3).  This figure has risen since 1996, when
41.8% of all users were female.  The first year when data for new users were analysed was
1998 and then 46.0% of reported new users were female.  Therefore the proportion of new
users who are female has also risen.  All Health Authorities reported greater numbers of
females than in previous years .  In Liverpool, where some services are specifically aimed at
females, in particular female prostitutes, nearly all clients (95.0%) were female.  Wirral has simi-
larly targeted services and they reported over four-fifths (84.4%) as female.   The overall male
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.
Table 4.3 All Users Reported by Outreach Services in 1999 by Sex and Health Authority of
Reporting Agency
All Users                                             New Users
Health Authority Female                 Male            Total Female Male Total
(100%) (100%)
Liverpool 151  (95.0%) 8 (  5.0%) 159 73  (98.6%) 1 (  1.4%) 74
Sefton 72  (34.3%) 138  (65.7%) 210 36  (38.3%) 58 (61.7%) 94
South Cheshire 472  (54.1%) 401  (45.9%) 873 300  (57.9%) 218  (42.1%) 518
St Helens & Knowsley 145  (37.5%) 242  (62.5%) 387 132  (40.1%) 197 (59.9%) 329
Wirral 1,031 (84.4%) 190  (15.6%) 1,221 363  (96.8%) 12  (  3.2%)    375
T otal 1,871 (65.6%) 979  (34.4%) 2,850  904 (65.0%) 486  (35.0%) 1,390
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.Authority of Reporting Agency
Drug
Methadone Sedatives Solvents Various Drugs              Others Total
(100%)
1 (  0.9%) 1 (  0.9%) 1 (  0.9%) 0 (  0.0%) 0 (  0.0%) 116
1 (  1.6%) 0 (  0.0%) 1 (  1.6%) 0 (  0.0%) 0 (  0.0%) 62  
7 (  3.8%) 2 (  1.1%) 0 (  0.0%) 13 (  7.1%) 4 (  2.2%) 182
4 (  4.8%) 2 (  2.4%) 0 (  0.0%) 3 (  3.6%) 2 (  2.4%) 84
32 (  7.4%) 0 (  0.0%) 3 (  0.7%) 135 (31.3%) 16 (  3.7%) 432
18 (13.5%) 0 (  0.0%) 3 (  2.3%) 49 (36.8%) 2 (  1.5%) 133   
7 (  2.4%) 1 (  0.3%) 4 (  1.3%) 103 (34.7%) 7 (  2.4%) 297
6 (  2.5%) 0 (  0.0%) 4 (  1.7%) 84 (35.0%) 7 (  2.9%) 240
36 (  5.9%) 10 (  1.6%) 5 (  0.8%) 86 (14.0%) 52 (  8.4%) 613
15 (  6.7%) 2 (  0.9%) 3 (  1.3%) 84 (37.3%) 14 (  6.2%) 225
83 (  5.1%) 14 (  0.9%) 13 (  0.8%) 337 (20.5%) 79 (4.9%) 1,640
44 (  5.9%) 4 (  0.5%) 11 (  1.5%) 220 (29.6%) 25 (3.3%) 744
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to female ratio was 1:1.9.  However this varied from 1:0.5 in Sefton to 1:18.8 in Liverpool.
Sefton and St Helens and Knowsley reported the lowest proportion with less than half their
clients being female.  These figures are encouraging in terms of the Government’s drug strategy
which emphasises the inclusion of females in treatment and supportive services.  Outreach ser-
vices may represent a ‘gateway’ into more formal services and this rise in females seen by out-
reach workers may lead to increased numbers in treatment.
Table 4.4 shows the reported main drug for all users and new users, broken down by Health
Authority.  Main drug is recorded only on first contact with a client and therefore may change
over time without being reflected in later reports.  The figure for new users may, therefore,
better reflect the current patterns of drugs being used by those accessing outreach services.
However, main drug was recorded for only 50% of new users and 49% of all users.  The
most commonly recorded drug amongst new users was heroin accounting for 43.3% of indi-
viduals.  However, in Liverpool and Sefton the proportions reporting heroin use were much
higher (93.5% and 60.7%, respectively).  In contrast while in South Cheshire only a quarter
(24.8%) of new users reported heroin as their main drug.  However, this still represented the
most commonly reported drug in the Health Authority.  In 1998 half of new users (50.5%)
reported using heroin (c.f. 1999, 43.3%).  Wirral reported 58.1% of individuals with heroin as
the main drug in 1998 compared to 32.9% in 1999 and in St Helens and Knowsley reporting
63.2% and 44.2%, respectively.  Data for new users are not available for previous years.
Anabolic steroids (AS) were rarely reported as the main drug of use, accounting for just 1.3%
of all and new contacts.  However, SES, particularly in  North Cheshire, Sefton and St Helens
and Knowsley, have been reporting high or increasing numbers of AS users.  Therefore, it may
be that gyms would provide a good site for outreach workers to make contact with those AS
users who are not currently in contact with services.Health Authority
Client Type Liverpool Sefton
Customer of Prostitute All Users 0 (  0.0%) 0 ( 0.0%)
New Users 0 ( 0.0%) 0 ( 0.0%)
Injecting Drug User: All Users 2 ( 1.3%) 97 (49.5%)
New Users  2 ( 2.7%) 39 (41.5%)
Injecting Prostitute All Users 60 (37.7%) 2 ( 1.0%)
New Users 20 (27.07%) 0 ( 2.1%)
Non Injecting Drug User: All Users 13 ( 8.2%) 92 (46.9%)
New Users 9 (12.2%) 50 (53.2%)
Other Sexually Active Person:  All Users 3 ( 1.9%) 2 ( 1.0%)
New Users 1 ( 1.4%) 2 ( 2.1%)
Prostitute: All Users 78 (49.1%) 3 ( 1.5%)
NewUsers 42 (56.8%) 3 ( 3.2%)
Other: New Users 3 ( 1.9%) 0 ( 0.0%)
All Users 0 ( 0.0%) 0 ( 0.0%)
Total (100% within HA):                All Users                       159 196
New Users                        74 94
Table 4.5 shows client type broken down by Health Authority as recorded on the individuals
first contact with services.  As with main drug of use, client type may change over time e.g.
from injecting drug user to non injecting drug user, and so details of new users may more accu-
rately reflect the types of client seen by outreach workers.  Client type was recorded for
86.3% of new users and 68.0% of all users.  The most commonly reported types of clients are
injecting and non-injecting drug users accounting for two thirds of users (69.4%) and new users
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Table 4.5 All Users and New Users Reported by Outreach Services in 1999 by Health Authority of
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.(62.5%) down from three quarters of users (78.1%) and new users (77.8%) in 1998.  There
has been a rise in contact with prostitutes from 8.6% (users) and 9.3% (new users) in 1998 to
9.4% and 10.4% in 1999.  This may be connected with the rise in the proportion of females
reported.  This is especially true of Liverpool where contacts with all prostitutes rose from
52.4% of users and 51.3% of new user in 1998 to 86.8% and 83.3% in 1999.  Contacts with
‘other sexually active people’ (which includes gay and bisexuals) have risen from 2.3% (users)
and 2.9% (new users) to 12.0% and 19.6%, respectively.
Health Authority
South St Helens &
Cheshire Knowsley Wirral Total
8 ( 0.9%) 1 ( 0.3%) 3 (  0.5%) 12 (  0.5%)
8 ( 1.6%) 1 ( 0.3%) 3 (  1.2%) 12 (  0.9%)
201 (23.3%) 193 (50.0%) 248 (37.9%) 741 (32.8%)
46 ( 8.9%) 147 (44.8%) 74 (28.7%) 308 (24.3%)
2 ( 0.2%) 2 ( 0.5%) 39 (  6.0%) 105 (  4.7%)
1 ( 0.2%) 1 ( 0.3%) 1 (  0.4%) 23 (  1.8%)
307 (35.6%) 139 (36.0%) 276 (42.2%) 827 (36.6%)
155 (30.1%) 134 (40.9%) 137 (53.1%) 485 (38.2%)
257 (29.8%) 4 ( 1.0%) 5 (  0.8%) 271 (12.0%)
239 (46.4%) 3 ( 0.9%) 4 (  6.1%) 249 (19.6%)
79 ( 9.2%) 13 ( 3.4%) 40 (  6.1%) 213 ( 9.4%)
65 ( 12.6%) 12 ( 3.7%) 10 (  3.9%) 132 (10.4%)
9 ( 1.0%) 34 ( 8.8%) 43 (11.2%) 89  (  3.9%)
1 ( 0.2%) 30 ( 9.1%) 29 (11.2%) 60 (  4.7%)
863 386 654 2,258
515 328 258                             1,269
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Reporting Agency and Client TypeTable 4.7 In Receipt of a Prescription? All Users, New Users and Contacts Reported by Outreach 
Services in 1999 by Health Authority of Reporting Agency
Receiving Prescription?
Health                                              All Users New Users Contacts
Authority                                  No Yes No Yes No Yes
Liverpool 140  (89.2%) 17  (10.8%) 66  (89.2%) 8 (10.8%) 622  (93.1%) 46 (  6.9%)
Sefton 158  (80.6%) 38  (19.4%) 72  (76.6%) 22  (23.4%) 856  (84.3%) 160 (15.7%)
South Cheshire 758  (87.3%) 110  (12.7%) 492  (94.8%) 27  (  5.2%) 1,605  (74.1%) 562 (25.9%)
St Helens & Knowsley 249  (64.3%) 138  (35.7%) 219  (66.6%) 110  (33.4%) 857  (46.9%) 971 (53.1%)
Wirral 385  (53.7%) 332  (46.3%) 235  (77.3%) 69  (22.7%) 1880  (38.0%) 3,068 (62.0%)
Total 1,690 (72.7%) 635 (27.3%)   1,084 (82.1%)   236 (17.9%) 5,820 (54.8%) 4,807 (45.2%)
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.
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Table 4.6 shows how the initial contact between the client and outreach worker was estab-
lished, analysed by Health Authority of reporting agency.  The data were collected for 60% of all
users and 94% of new users.  The most common methods of meeting in 1999 were to be
introduced through another client (37.3% of users and 30.8% of new users), outreach worker
making direct approach to the client (28.0% and 29.3%, respectively) or the client approaching
the worker directly ( 24.4% and 28.1%, respectively).  In Liverpool Health Authority only one
individual was not approached directly by an outreach worker and this may reflect the nature of
work with prostitutes.  
Table 4.6 All Users and New Users Reported by Outreach Services in 1999 by Health Authority                    
Health Authority
How Met Liverpool Sefton
Approached directly by client All Users 0 (    0.0%) 68 (34.7%)
New Users 0 (    0.0%) 36 (38.3%)
Introduced by agency worker:     All Users 0 (    0.0%) 21 (10.7%)
New Users 0 (    0.0%) 12 (12.8%)
Introduced by another client:        All Users 1 (    0.6%) 71 (36.2%)
New Users 0 (    0.0%) 30 (31.9%)
Introduced by drug dealer:            All Users 0 (    0.0%) 0 (  0.0%)
New Users 0 (    0.0%) 0 (  0.0%)
Made direct approach to client:    All Users 159 (  99.4%) 34 (17.3%)
New Users   74 (100.0%) 14 (27.7%)
Old client *:                                   All Users 0 (    0.0%) 2 (  1.0%)
Total (100% within HA) :            All Users 160 196
New Users 74 92
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency. *Old clients are those who were first in contact                        Table 4.7: Individuals were asked on their first contact with an outreach worker whether they
were receiving a prescription as a treatment for drug dependency.  This may change over time
without being reflected in later reports and so details from new users may give the most reliable
data.  The proportion of all users receiving a prescription has changed little over the last three
years from 30.5% in 1997 and 1998 to 27.3% in 1999.  Amongst new users the rate is lower
but remains relatively static; 17.3% in 1998 and 17.9% in 1999 (data for new users are not
available for previous years).  This low rate among new users may indicate that outreach services
are increasingly contacting a population of drug users who are not receiving treatment from
other services.  This is supported by the low rate of methadone reports (5.9% of new users,
see Table 4.4).  However of the 44 new users who reported using methadone as their main
drug, 84.1% stated that they were in receipt of a prescription.  Low reported attendance at
syringe exchanges (10.9%, see Table 4.8) also points to this population of outreach clients not
being in contact with other specialist services.  Those users in receipt of a prescription made, on
average, more contacts with outreach services in the year than those not receiving a prescrip-
tion: 7.6 contacts and 3.4 contacts.
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                  of Reporting Agency and How They Met the Outreach Worker
Health Authority
South St Helens  Wirral Total
Cheshire & Knowsley
302 (34.7%) 81 (21.1%) 35 (  9.3%) 486 (24.4%)
257 (49.5%) 61 (18.7%) 35 (  9.5%) 389 (28.1%)
53 (  6.1%) 86 (22.4%) 9 (  2.4%) 169 (  8.5%)
40 (  7.7%) 76 (23.3%) 8 (  2.2%) 136 (  9.8%)
325 ( 37.3%) 156 (40.6%) 188 (49.9%) 741 (37.3%)
72 ( 13.9%) 138 (42.3%) 186 (50.4%) 426 (30.8%)
2 (  0.2%) 1 (  0.3%) 3 (  0.8%) 6 (  0.3%)
1 (  0.2%) 1 (  0.3%) 3 (  0.8%) 5 (  0.4%)
177 ( 20.3%) 55 (14.3%) 131 (34.7%) 556 (28.0%)
144 ( 27.7%) 47 (14.4%) 126 (34.1%) 405 (29.3%)
12 (  1.4%) 5 (  1.3%) 11 (  2.9%) 30 (  1.5%)
871 384 377 1,988
514 323 358 1,361
                       with Outreach services before this monitoring system was implemented and method of meeting is not known.  New clients cannot be of this type.Table 4.8 shows whether, at the time of first contact with an outreach worker, an individual was
also attending an SES, by Health Authority of reporting agency.  These data were recorded for
68.8% of all users and 87.0% of new users.  This question was only asked at the first contact
between the outreach worker and the client and may change over time without being reflected
in later reports.  Therefore the figures for new users may give the most reliable indicator of the
SES activity of Outreach clients.  Only 10.9% of new users and 15.2% of all users were also
attending a syringe exchange (9.5% and 17.0%, respectively in 1998).  The contact rates for
those attending syringe exchanges was 7.7 contacts a year and 4.1 for those not in contact with
SES.  In 1996 the corresponding rates were 4.6 and 4.4, respectively.
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Table 4.8 Attending SES?  All Users, New Users and Contacts Reported by Outreach Services in
1999 by Health Authority of Reporting Agency
Attending SES?
Health All Users New Users Contacts
Authority No Yes No Yes No Yes
Liverpool 139  (90.3%) 15  (  9.7%) 70  (94.6%) 4 (  5.4%) 583  (88.9)% 73  (11.1%)
Sefton 155  (79.5%) 40  (20.5%) 70  (74.5%) 24  (25.5%) 830  (82.2%) 180  (17.8%)
South Cheshire 834  (96.2%) 33  ( 3.8%) 509  (98.1%) 10  (  1.9%) 2,070  (95.6%) 96  (  4.4%)
St Helens & Knowsley 293  (75.5%) 95 (24.5 %) 263  (79.7%) 67  (20.3%) 1,098  (60.0%) 731  (40.0%)
Wirral 513  (75.9%) 163  (24.1%) 228  (87.0%) 34  (13.0%) 3,317  (67.7%) 1,584  (32.3%)
Total (100%) 1,934 (84.8%) 346 (15.2%) 1,140 (89.1%) 139 (10.9%) 7,898 (74.8%) 2,664 (25.2%)
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.Table 4.9:  The setting of the contact between the client and the outreach worker was record-
ed in 98.5% of all contacts compared to 76.3% in 1998, 64.2% in 1997 and 94.8% in 1996.
As in all four previous years the most commonly reported locations of contact were in the
client’s home (around a half of contacts each year) and the street (around a third of contacts
each year).  However, there was considerable variation in different Health Authorities.  In
Liverpool 98.8% of clients were seen on the street and 0.1% in the clients home.
In St Helens and Knowsley and Sefton Health Authorities, SES have been reporting increasing
numbers of anabolic steroid users over the past three years (see Tables 2.7a and 2.7b and
Figure 2.4c) which may indicate increasing prevalence of these drugs in these areas.  However
there were few reports of any outreach contacts in gyms in these Health Authorities.  Outreach
work in or around gyms may be a good way of contacting AS users who are not currently in
contact with any services.  
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Table 4.9 All Users Reported by Outreach Services in 1999 by Setting of Meeting Between 
Outreach Worker and Client by Health Authority of Reporting Agency
Health Authority
Liverpool  Sefton South St Helens  Wirral Total
Cheshire & Knowsley
Advice / Info. Centre 0 (  0.0%) 4 (  0.1%) 0  (  0.0%) 0  (  0.0%) 101  (  1.6%) 105 (  0.7%)
Car 0 (  0.0%) 0 (  0.0%) 239 (  9.7%) 14 (  0.7%) 0  (  0.0%) 253 (  1.6%)
Criminal Justice Service 
1 0 (  0.0%) 3 (  0.1%) 11 (  0.4%) 6 (  0.3%) 7 (  0.1%) 27 (  0.2%)
Drug Service 0 (  0.0%) 2 (  0.1%) 47 (  1.9%) 150 (  7.8%) 158 (  2.5%) 357 (  2.4%)
Education 
2 0 (  0.0%) 0 (  0.0%) 221 (  9.0%) 38 (  2.0%) 0  (  0.0%) 259 (  1.7%)
GP / Health Centre 0 (  0.0%) 5 (  0.2%) 4 (  0.2%) 1 (  0.1%) 0  (  0.0%) 10 (  0.1%)
Gym 0 (  0.0%) 0 (  0.0%) 110 (  4.5%) 8 (  0.4%) 0  (  0.0%) 118 (  0.8%)
Hospital 0 (  0.0%) 38 (  1.3%) 8 (  0.3%) 30 (  1.6%) 38 (  0.6%) 114 (  0.8%)
Home 1 (  0.1%) 1,245 (  43.9%) 1,139 (46.4%) 902 (46.7%) 4,382 (68.4%) 7,669 (51.2%)
Hostel 
3 0 (  0.0%) 92 (  3.2%) 4 (  0.2%) 61 (  3.2%) 0  (  0.0%) 157 (  1.0%)
Massage Parlour 15 (  1.1%) 18 (  0.6%) 164 (  6.7%) 0  (  0.0%) 19 (  0.3%) 216 (  1.4%)
Pharmacy 0 (  0.0%) 0 (  0.0%) 1 (  0.0%) 1 (  0.1%) 0  (  0.0%) 2 (0.0%)
Public Place 
4 0 (  0.0%) 51 (  1.8%) 126 (  5.1%) 34 (  1.8%) 3 (  0.0%) 214 (  1.4%)
Syringe Exchange 
5 0 (  0.0%) 0 (  0.0%) 0  (  0.0%) 11 (  0.6%) 0  (  0.0%) 11 (  0.1%)
Shooting Gallery 
6 0 (  0.0%) 427(15.1%) 0  (  0.0%) 0  (  0.0%) 0  (  0.0%) 427 (  2.8%)
Street 1,348 (98.8%) 937(33.1%) 377 (15.4%) 515 (26.6%) 1,553 (24.3%) 4,730 (31.6%)
Other 0 (  0.0%) 11 (  0.4%) 4 (  0.2%) 162 (  8.4%) 143 (  2.3%) 320 (  2.1%)
Total (100%)          1,364 2,833                  2,455                 1,933 6,404 14,989 
Data are for all users and visits, including multiple counts of individuals who presented at more than one agency.
1Police, probation, prison, court etc  
2School, college, university etc 
3Including YMCA, shelter, guest house, hotel  
4Church, youth club, cafe, bus, railway station, 
community centre etc  
5Including mobile syringe exchange  
6A communal injecting arena.70
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SECTION 5
MULTI-AGENCY-TYPE VISITORS71
Introduction
This section of the report outlines the number of individuals who visited more than one type of
agency in Merseyside or Cheshire during 1999.  This analysis depends on the provision of
attributor data (initials, date of birth and sex), and three service types (Pharmacy and agency
based syringe exchange and specialist drug services) collect this.  In 1999 Liverpool Pharmacies
began collecting attributor data and so are included here.
Of the 7,697 individuals reported by SDS in 1999, and for whom full attributor data had been
provided, a fifth (1,847 individuals or 23.9%) also visited one or both types of syringe exchange.
This represents considerable numbers of individuals who are receiving treatment at SDS for
their drug problems who are probably continuing to inject, and does not necessarily represent
all those who continue to inject despite undertaking treatment.  Others may not appear at any
services.  Of the 1,847 individuals, 23.3% (430 individuals) visited both types of SES, 44.8%
Figure 5.1 All Users in Contact with Specialist Drug Services, Pharmacies and 
Syringe Exchange Schemes in 1999
SDS=Specialist Drugs Agency SES=Agency Based Syringe Exchange Pharmacy=Pharmacy Syringe Exchange
SDS
5,850
Pharmacy
2,910
SES
2,233
430
590  276
827
SDS=(n=7,697)  Pharmacy=(n=4,443)
SES=(n=3,529)72
(827 individuals) visited only a Pharmacy and 31.9% (590 individuals) visited only an agency
based syringe exchange.  Of the 7,266 individuals who visited a syringe exchange (Pharmacy or
agency based), 706 individuals or 9.7% visited both types of SES, suggesting that the two differ-
ent types of syringe exchanges are attracting different populations of injecting drug user and are
complementary in their service.
A pilot project to collect attributor data from clients of one outreach service (based at the
Maryland Centre) began early in 2000 and so in future reports it may be possible to analyse the
degree to which Outreach clients are also contacting other agency types.73
APPENDIX 1
APPENDIX 1
COMPARISON OF VISIT/CONTACT RATES BY AGENCY TYPE74
Comparison of Visit and Contact Rates by Agency Type
Appendix I shows the comparison between the visit / contact rates (average number of visits or
contacts per user per year) at the different services (agency and Pharmacy based Syringe
exchange schemes and Outreach services) across the Merseyside and Cheshire Health
Authorities.  Pharmacies generally reported much higher visit rates than other services although
in St Helens and Knowsley Health Authority SES clients made more visits per year. The high
visit rate at pharmacy based services may be the result of the more anonymous service that
they offer.  Pharmacies reported between 7.4 and 15.0 visits per year, SES reported from 2.2
to 7.7 visits and Outreach reported between 2.7 and 7.5 visits.  No Outreach services were
undertaken in North Cheshire during 1999.
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Outreach Contacts
Agency SES Visits
Pharmacy Visits
Comparison of Visit/Contact Rates at Agency and Pharmacy Based Syringe 
Exchange Schemes and Outreach Services in 199975
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APPENDIX 2
MAP OF AGENCIES REPORTING TO THE
DRUG MONITORING UNIT76
Appendix 2. Location of agencies reporting to the Drug Monitoring Unit
ARCH Initiatives  17
ARCH Initiatives Residential  18
Chester CDT  1
Dual Action Response Team  19
Ellesmere Port CDT 2
Halton DDU  3
Integrated Care Team  20
The Kevin White Unit  21
Kirkby CDT  4
Lifeline  5
Liverpool Bail Support  22
Liverpool DDU  23
Liverpool MDC  24
Macclesfield CDT  6
The Maryland Centre  7
Newton-le-Willows CDT  8
North Liverpool CDT  9
The Oakmere Unit  25
Phoenix House  26
Response  27
SHADO  28
South Cheshire CDT  10
South Knowsley CDT  11
Southport  CDT  29
Southport MDC  14
South Sefton CDT  12
South Sefton MDC  13
St Helens CDT  15
Turning Point  30
U-Turn Project  31
Warrington CDT   32
Wirral Drugs Service  33
Wirral HIV & AIDS Prevention  16
+ = Pharmacy Based Syringe Exchange77
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APPENDIX 3
LOCATIONOF AGENCIES REPORTING TO THE
DRUG MONITORING UNIT78 78
ARCH Initiatives
Birchwood
23 - 25 Balls Road
Birkenhead
Wirral
L41 6HH
RES
ARCH Initiatives
1st Floor, Argyle Health
Centre
Oliver Street East
Birkenhead
Wirral 
L41 6HH
SDS
Chester CDT
Mill House
Russell Street
Chester
CH3 5AL
SDS; SES; OUT
Dual Action Response
Team (DART)
Substance Misuse Service
Mid Cheshire Hospitals
Breedon House
Edleston Road
Crewe
CW2 7EA
SDS; YOU
Ellesmere Port CDT
6, Shrewsbury Road
Ellesmere Port
Wirral
SES (included in Chester
CDT figures); 
OUT (included in Chester
CDT figures)
Halton DDU
74, Victoria Road
Widnes
WA8 7RA
SDS; SES; OUT
The Integrated Care
Team
3 - 5 Rodney Street
Liverpool
L1 9ED
SDS
The Kevin White Unit
Sefton General Hospital
Smithdown Road
Liverpool
L15 2HE
RES
Kirkby CDT
The Clark Centre
Cherryfield Drive
Kirkby
Merseyside
L32 8SE
SDS; SES; OUT (non report-
ed in 1998)
Lifeline
45, Wilson Patten Street
Warrington
WA1 1PG
SES
Liverpool Bail Support
Scheme
Liverpool MDC
27, Hope Street
Liverpool
L1 9BQ
SDS
Liverpool DDU
Hope House
26, Rodney Street
Liverpool
L1 2TQ
SDS
Liverpool MDC
27, Hope Street
Liverpool
L1 9BQ
SDS
Macclesfield CDT
Bridge house
15, Brook Street
Macclesfield
Cheshire
SK11 6AA
SDS; SES
The Maryland Centre
8, Maryland Street
Liverpool
L1 9BX
SES; OUT
Newton-le-Willows CDT
29, Queen Street
Newton-le-Willows
WA12 9AS
SDS; SES
KEY:
The three letter code indicates the types of services offered during 1999, as follows:
SES: Agency based Syringe Exchange services SDS: Specialist Drug Services
OUT: Outreach services  RES: Residential detox. or rehabilitation79
North Liverpool CDT
The Outpost
Queens Drive Family
Centre
Moore Lane
Walton
Liverpool
L4 6SO
SDS; SES; OUT
The Oakmere Unit
West Cheshire Hospital
Liverpool Road
Chester
CH2 1UL
RES (now closed)
Phoenix House
Upton Road
Bidston
Wirral
L34 7QF
RES
Response
The Callister Centre
19, Argyll Street
Birkenhead
L41 1AD
OUT
SHADO
Family Support Centre
Stonebridge Lane
Liverpool
L11 4SJ
SDS
South Cheshire CDT
67 - 69  Eddleston Road
Crewe
Cheshire
CW2 7HP
SDS; SES; OUT
South Knowsley CDT
Skelton house
Lathom Road
Huyton village
L36 9FH
SDS; SES; OUT
South Sefton CDT
18, Great George's Road
Waterloo
Liverpool
L22 1RB
SDS; SES
South Sefton MDC
482, Stanley Road
Bootle
Merseyside
L20 5AF
SES; OUT
Southport DDU
46, Houghton Street
Southport
Merseyside
PR9 0PQ
SDS
Southport MDC
46, Houghton Street
Southport
Merseyside
PR9 0PQ
SDS; SES; OUT
St Helens CDT
46 - 48 Claughton Street
St Helens
Merseyside
WA10 1SN
SDS; SES; OUT
Turning Point
27, Hoole Road
Chester
CH2 3NH
RES
The U-Turn Project
ARCH Initiatives
1st Floor, Argyle Health
Centre
Oliver Street East
Birkenhead
Wirral 
L41 6HH
SDS
Warrington CDT
9, Wilson Patten Street
Warrington
WA1 1PG
SDS
Wirral Drugs Service
St Catherine's Hospital
Church Road
Tranmere
Wirral
L42 0LQ
SDS;
Wirral HIV & AIDS
Prevention
The Lodge
St Catherine's Hospital
Church Road
Tranmere
Wirral
L42 0LQ
SES; OUT80
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